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Abstract 
 
Genotoxicity of Acrylic Resin: In Vitro Study on Gingival Fibroblasts 
 
Poly-methyl methacrylate based materials have a wide range of applications in 
prosthodontics and orthodontics. However, complete polymerization of the methyl 
methacrylate monomer is never achieved and may therefore leach into the oral 
environment in physiological conditions. It has been often associated with adverse 
biological effects such as allergic reactions in the patients’ oral mucosa and contact 
sensitization/irritation in dental professionals.  
In the present study we hypothesized whether the residual monomer leached in 
approximate clinical conditions is capable of inducing in vitro cytotoxic and/or genotoxic 
hazards to a human gingival fibroblast cell line. 
All methodologies in this study followed ISO standards and international 
guidelines. At first, heat polymerizable acrylic resin samples were fabricated and then 
submersed independently in artificial saliva for 24 or 72 hours at 37ºC, in order to 
simulate the mouth clinical conditions. The leached residual monomer was quantified 
by means of high performance liquid chromatography.  
Moreover, a thoroughly characterization of the methyl methacrylate cytotoxic 
profile on the viability of human gingival fibroblasts was performed and compared to 
that on human fetal lung fibroblasts and chinese hamster lung fibroblasts. Ethyl 
methanesulfonate and formaldehyde were tested as well as positive controls. Methyl 
methacrylate showed to be cytotoxic to human gingival fibroblasts, for concentrations 
ranging 40 to 160 mM. However, the determined values for the leached residual 
monomer from polymerized pieces were 105- fold less concentrated, which does not 
cytotoxically affect the cells. Subsequently, the genotoxicity effect of these three 
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chemicals was also determined using human gingival fibroblasts and chinese hamster 
lung fibroblasts, by means of the micronuclei in vitro test. 
 Within the limitations of this in vitro research, the outcomes show that the 
residual monomer leached by the polymer tested does not affect cyto and genotoxically 
the cell lines tested. Moreover, it provided some evidence that the human gingival 
fibroblast cell line is a good model for cytotoxicity assays. Still, further studies must be 
developed so as to draw definite conclusions on the suitability of these cells as oral 
models for the micronuclei in vitro test. 
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Resumo 
 
Genotoxicidade das Resinas Acrílicas: Estudo In Vitro em Fibroblastos 
Gengivais 
 
 Os materiais baseados no poli-metil metacrilato têm uma ampla aplicabilidade 
em prótese dentária e ortodontia. No entanto, a reação de polimerização do monómero 
de metil metacrilato nunca é completa, podendo ocorrer lixiviação para o meio oral em 
condições fisiológicas. Tem sido associado recorrentemente a efeitos biológicos 
adversos como reações alérgicas na mucosa oral de pacientes e a 
sensibilização/irritação de contacto em profissionais dentários. 
No presente estudo formulou-se a hipótese de que o monómero residual 
lixiviado em condições clínicas aproximadas poderia induzir danos citotóxicos e/ou 
genotóxicos in vitro numa linha celular de fibroblastos gengivais humanos. 
 Todos os métodos deste estudo seguiram normas ISO e diretivas 
internacionais. Em primeiro lugar, produziram-se amostras de resina acrílica termo-
polimerizável, que foram submersas independentemente em saliva artificial durante 24 
ou 72 horas a 37ºC, de modo a simular as condições clínicas da cavidade oral. O 
monómero residual lixiviado foi quantificado por cromatografia líquida de alta 
eficiência. 
 Além disso, realizou-se uma caracterização meticulosa do perfil citotóxico do 
metil metacrilato na viabilidade dos fibroblastos gengivais humanos e comparou-se 
com o de fibroblastos fetais de pulmão humano e fibroblastos de pulmão de hamster 
chinês. O etil metanossulfonato e formaldeído foram também testados como controlos 
positivos. O metil metacrilato mostrou ser citotóxico para os fibroblastos gengivais 
humanos, para concentrações a variar entre 40 e 160 mM. No entanto, os valores 
determinados para o monómero residual lixiviado das peças polimerizadas foram 
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cerca de 105 vezes menos concentrados, o que não afeta as células ao nível 
citotóxico. Subsequentemente, o efeito genotóxico destas três substâncias químicas 
também foi determinado para os fibroblastos gengivais humanos e fibroblastos de 
pulmão de hamster chinês, através do teste de micronúcleos in vitro. 
 Dentro das limitações desta pesquisa in vitro, os resultados mostram que o 
monómero residual lixiviado pelo polímero testado não afeta cito nem 
genotoxicamente as linhas celulares testadas. Além disso, forneceu alguma evidência 
de que a linha celular de fibroblastos humanos gengivais são um bom modelo para 
ensaios de citotoxicidade. No entanto, é necessário desenvolver estudos adicionais 
para que se possam retirar conclusões definitivas sobre a adequação destas células 
como modelos orais para o teste de micronúcleos in vitro. 
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 Dental acrylic resins are biomaterials that are commonly used for the fabrication 
of oral devices in the prosthodontic field. The present research project intends to 
develop methodologies to evaluate the amount of leachable molecules released by a 
conventional heat-polymerizable denture base polymer and their potential harmful 
effects. The biological risk assessment will include cytotoxic and genotoxic in vitro 
assays performed on an oral cell model.  
 
 
A.1. Oral Rehabilitation and Dental Polymers 
 
 Edentulism can be defined as a state of loss of all natural permanent teeth1 and 
is considered by the World Health Organization as a physical impairment.2 It is a global 
health problem, affecting the populations of both developed and developing countries, 
with an estimated international prevalence between 7 and 69%.2 Despite the recent 
improvements in oral health care, there are still barriers to public preventive oral 
treatments and too many people are still being affected by oral chronic diseases like 
caries and periodontitis, which lead to the partial or total loss of teeth.2,3 Other 
biological conditions like pulpal pathology, trauma and oral cancer, or the socio-
economical circumstances (gender, income, education level, access to health care, 
culture) also account for tooth loss.2 It has also been related to several systemic 
diseases like osteoporosis, hypertension and coronary artery disease, respiratory 
illnesses, diabetes, neuropathies, rheumatoid arthritis and cancer, as well as oral 
conditions such as alveolar ridge resorption, impairment of the oro-facial function 
(mastication, speech) and esthetics.2 Moreover, edentulism has been associated with 
increasing age, which nowadays is becoming a global issue, with the aging of the 
populations, especially in developed countries.4 As a consequence, the peoples’ needs 
in terms of prosthodontic partial and total rehabilitation are growing as well.4 
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 Generally speaking, a prosthesis is an artificial therapeutic device which 
substitutes a missing part of the body, improving or changing its function.1 More 
specifically, a dental prosthesis (denture) is an artificial device that substitutes the 
missing teeth (partial or total edentulism) and associated dental/alveolar structures,1 
which may as well include any additions needed for optimum function.5 Therefore, it 
can be considered a medical device since it is an apparatus (…)/ appliance (…) 
intended by the manufacturer to be used, alone or in combination, for human beings 
(…) with the purpose of (…) replacement, modification or support of the anatomy or of 
a physiological process.6 Dental prostheses (as well as orthodontic appliances) are 
permanent surface-contacting devices (with mucosal membranes), since the 
cumulative single, multiple or repeated long-term use frequently exceeds 30 days.6 
Many times, this close contact is promoted by the denture base that rests on the soft 
tissue foundations and to which the artificial teeth are attached.1,5 One of the most 
fundamental requirements of the denture base is its adaptation, which is its degree of 
fit to the supporting area, including the surface of the palate, maxillary and mandibular 
edentulous ridges, best suited to carry the chewing forces during the denture’s 
function.1 Base adaptation is one of the factors that influence the retention of a denture, 
avoiding the vertical dislodging forces along the path of placement, away from the 
supporting tissues.1,7 For that reason, it may be stated that the base adaptation directly 
contributes to the patients’ acceptance and daily functional using of the denture, thus 
the treatment success.7 
Acrylic resin-based dental materials became popular in the decade of 1950 and 
since then the range of applications and products has increased and evolved 
considerably. Thus, the poly(methyl methacrylate) (PMMA) polymer is ubiquitous in the 
dental profession and not limited only to the fabrication of conventional removable 
prosthesis, but also in implant supported prosthodontics, orthodontic devices, denture 
liners, individual impression trays and temporary crowns.8,9 In addition, it is widespread 
in non-dental human use products like the orthopedic bone cements, intraocular lens, 
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prosthesis for plastic and reconstructive surgery or artificial fingernails and nail 
varnishes.9,10 
 
 
A.2. Physico-Chemical Features of Acrylic Resins 
 
A polymer is a high molecular weight chemical compound, which, by means of a 
repeated intermolecular chemical reaction (polymerization) becomes a long-chain 
and/or cross-linked macromolecule composed of several repetitive united molecules 
with a lower molecular weight (monomers).1,11,12 A polymer may be a fiber, a rigid or 
rubberlike material, depending on the form and morphology of the monomer. Although 
some polymers may be inorganic, in the dental field most of them are organic 
molecules, particularly derived from methacrylates (denture and orthodontic bases, 
restorative composite resins).12 Other types of polymers based on polyacrylic acid 
(PAA) (glass ionomers, adhesives) or poly(dimethylsiloxane) (PDMS) (soft denture 
liners) are also widely employed in dental practice.13 
In general, polymers may consist of only one type of molecule (homopolymer) 
or two or more kinds of monomers (copolymers).12 The monomers usually are mono- 
(e.g. methyl methacrylate – MMA) or di-methacrylates (e.g. 1,6-hexanediol 
dimethacrylate – 1,6-HDMA) and may even have more functional groups 
(multifunctional monomers), though the latter are more common in restorative 
composite resins (e.g. bisphenol A-glycidyl methacrylate – bis-GMA, triethylene glycol 
dimethacrylate – TEGDMA, urethane dimethacrylate – UDMA).12,13 UDMA is also very 
common in light and microwave cured denture and orthodontic base polymers.9 
Multifunctional monomers have been developed in order to reduce the materials’ 
viscosity and improve the polymerization efficiency.12 Individual monomer types have 
other different chemical features in terms of their hydrophilicity/lipophilicity. In a study 
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cited by Lai et al. (2004) it was reported that the logarithm of the octanol/water partition 
coefficient (log P) directly relates to lipophilicity.14 The hydroxyl groups on acrylates and 
methacrylates seem to contribute to the lipophilicity; also the longer the oxyethylene 
chains of the dimethacrylates like 1,6-HDMA and the longer the alkyl chains, the more 
hydrophobic.14 Moreover, as it will be further explored bellow, lipophilicity (and a higher 
log P) is related to longer retention times in high performance liquid chromatography 
(HPLC) runs in reversed phase columns.14 Though these monomers are not 
considered to be hydrophilic, they have some affinity to water and tend to absorb it or 
being dissolved.13 Additionally, the size of the monomers’ molecules is important, 
because smaller ones shall leach more easily than larger molecules.15-17 
Polymers may be characterized by their network structure: the length, the 
branching, the cross linking and organization of the chains. Cross linking consists of 
permanent connections between different chains.12 A more dense cross-linking results 
in a closed structure (composite resins), whereas a lower density arrangement 
generates a more open network (denture and orthodontic bases).13 Di-functional 
monomers such as ethyleneglycol dimethacrylate (EGDMA), trimethylolpropane 
trimethacrylate (TMPTMA) or 1,6-HDMA are usually employed to promote cross-
linking.8,9 As the polymer chain becomes longer, more branched and with more cross 
linking, the molecular weight increases, which is favorable to the mechanical and 
physical features of the material. Hence, it becomes more resistant to distortion, more 
rigid and the fusion temperature rises. Besides, materials with cross linking have a 
higher glass-transition temperature (softening temperature). Additionally, these 
features contribute to a polymer with a higher proportion of a random amorphous 
organization, which is preferable to a highly ordered structure, since crystallinity 
increases brittleness.12 
In general, dental polymers are considered insoluble in water, though imbibition 
may occur, resulting in undesirable dimensional alterations. The water/solvent 
molecules are adsorbed through the porosities and inter-chain spaces and expand the 
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matrix network (plastification).12,13,18,19 As a consequence, the polymer softens and 
swells, but does not dissolve, compromising the material’s clinical performance.12 
Moreover, it may also suffer oxidation and hydrolysis.13 If the tridimensional polymer 
network is more complex (high molecular weight, cross linking, crystalline regions and 
chain ramifications), it is does not absorb as much water and its solubility decreases.12. 
Water and other solvents may act as external plasticizers,12 while other molecules, 
including monomers (e.g. butyl methacrylate – BMA), work as internal plasticizers, 
which soften and reduce the resistance of materials, widely used in denture 
reliners.12,20 Since that PMMA is a linear polymer it is soluble in a variety of organic 
solvents such as acetone or chloroform.12 
According to the 8th Edition of the Glossary of Prosthodontic Terms PMMA is a 
stable, hard transparent resin of marked clarity with a Knoop hardness number ranging 
from 18-20, a tensile strength of approximately 60 MPa, a density of 1.19 g/ml and a 
modulus of elasticity of approximately 2.4 GPa.1 
Chemically speaking, polymerization may occur by two distinct processes: 
addition or condensation. The condensation (growth-step) reaction is typical of 
elastomers and it is characterized by a simultaneous reaction of the bifunctional 
monomers that gradually connect each other and many times, as a consequence, may 
produce low molecular weight byproducts. Conversely, during the addition 
polymerization, which is the most usual in the dental field, the monomers are activated 
one by one, but are rapidly added to the main chain without changing the composition 
and, theoretically, can produce almost unlimited giant molecules if monomer is 
available.12 Addition polymerization is divided in 4 main stages, as generally 
summarized in Table 1 and Figure 1. The addition polymerization reaction is 
exothermal, reaching considerably high temperatures. It has been reported that e.g. 
autopolimerizable PMMA acrylic bone cements peak temperature may range 50-
120ºC.21 
 
 
15 
Table 1. Main stages of the addition polymerization (adapted from 12) 
Stage General description Fig. 1 – Reaction diagram 
In
d
u
c
ti
o
n
 
A
c
ti
v
a
ti
o
n
 An activator agent breaks the –O–O– connection of the 
initiator molecule, creating two free radical sites with an 
unpaired electron (•) each.  
 
In
it
ia
ti
o
n
 
The unpaired electron interacts with another electron from 
the monomer’s double bond, creating a covalent bond. 
Consequently, a new electron becomes unpaired and 
available to establish new bonds with other monomers. 
 
P
ro
p
a
g
a
ti
o
n
 The unpaired electron of the complex free radical-
monomer interacts with the double bond of a new 
monomer, forming a dimer. The process is subsequently 
repeated, rapidly creating large macromolecules. 
 
C
h
a
in
 T
ra
n
s
fe
r 
When a hydrogen atom is donated by an active free 
radical to another monomer, the former chain becomes 
non-reactive and the free radical site is transferred to the 
monomer, which continues the reaction. It may also occur 
between two separate chains, where one passive chain 
becomes active and vice-versa.  
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It may result from a chain transfer where a previously 
active chain becomes inactive. More often, the terminal 
free radical sites of two separate chains establish a direct 
coupling or exchange a hydrogen atom and both become 
inactive. 
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The agents that promote the beginning of the addition polymerization will be 
discussed in the next section. In addition, the reaction may be inhibited or delayed by 
the presence of impurities and the contact with oxygen, which react with the free 
radical sites of either the activator agent or a growing polymer chain.12,22 Besides, 
hydroquinone (HQ) (<0.006%) may be added to the monomer composition as an 
inhibitory agent, avoiding its spontaneous polymerization.12,22 
 
 
A.3. Polymerization Methods and Classification of Dental Base Polymers 
 
One of the most popular and accepted criteria for the classification of dental 
base polymers is the polymerization method. As mentioned in the previous section, the 
beginning of the reaction requires an activation agent, which may vary in terms of the 
source and/or type, determining the nature of the polymerization method. The 
activation agent may be a secondary molecule, UV light, visible light, heat or 
transferred energy from another free radical site. The most common polymer general 
types used in dentistry and respective activator and initiator are listed in Table 2.9,12 
 
Table 2. Main polymerization methods used in dentistry 9,12 
Polymerization Activation agent Initiator molecule 
Thermo Heat (>65ºC) from water bath or microwave 
e.g. benzoyl peroxide 
Chemical/auto Tertiary amine (e.g. N,N-dimethyl p-toluidine) 
Light Visible light (~470 nm) e.g. camphorquinone 
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The most commonly used initiator in dental acrylic resins is benzoyl peroxide 
(BPO), which is activated between 50º and 100ºC. The higher the polymerization 
temperature, the faster will the formation of free radical sites occur and the shorter will 
the induction stage be.12 Therefore, a material is classified as a heat-polymerizable if it 
requires temperatures above 65ºC in order to polymerize.5 Conversely, an auto or 
chemical-polymerizable material does not require temperatures higher than 65ºC,5 
since the tertiary amine, which is packed separately, reacts with BPO during 
manipulation and together form a complex that does not require as much energy to 
break the –O–O– connection.9,12 For that reason, autopolymerizable materials can be 
activated and polymerized at room or the mouth temperature.12 
 On the other hand, in light cured materials the energy required for the induction 
of the reaction comes from an external source of radiation.23 UV light has been 
discarded because of its hazardous biological effects, limited penetration into the 
materials and decrease of the light source intensity with time. As a result, visible light in 
the spectrum of blue/violet (usually around 470 nm) is used to activate initiator 
molecules like camphorquinone.12 
 A more general classification takes into account the thermal properties of 
polymers. Most of them are thermo-rigid, since they are permanently hard and 
inflexible upon polymerization. Even if the material is re-heated until its polymerization 
temperature, its dimensional and structural features do not change. Besides, their 
mechanical properties are better and are virtually insoluble.12 Conversely, 
thermoplastic polymers are softened after the application of heat above its glass 
transition temperature and become moldable because the distance between the 
molecular chains increases. They return to their hardened state upon cooling and may 
be re-heated and re-molded several times, though their physical characteristics are not 
so advantageous.5,12 
 The International Organization for Standardization (ISO) has also established a 
classification for both denture and orthodontic base polymers, which is presented in 
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Table 3. Besides, according to the type of polymer considered, it should comply with 
certain characteristics, namely the maximum content of unpolymerized residual 
monomer,5,23 which will be further discussed in the next section. 
 
Table 3. Classification of base polymers and maximum residual monomer 5,23 
ISO Reference Classification Material 
Residual MMA monomer 
(% mass fraction max.)* 
ISO 20795-1:2008 
Denture base 
polymers 5 
Type 1 
Class 1 
Class 2 
Heat-polymerizable 
Powder/liquid 
Plastic cake 
2.2 
Type 2 
Class 1 
Class 2 
Autopolymerizable 
Powder/liquid 
Powder/liquid (pour-type) 
4.5 
Type 3 Thermoplastic 2.2 
Type 4 Light-activated 2.2 
Type 5 Microwave cured 2.2 
ISO 20795-2:2010 
Orthodontic base 
polymers 23 
Type 1 Autopolymerizable 5 
Type 2 Light-activated 5 
Type 3 Thermoplastic 5 
* Residual monomer content shall not be more than 0.2% higher than that claimed by the manufacturer 
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A.4. Residual Monomer Content and Leaching 
 
It has been broadly described in the literature that total polymerization of the 
monomer is never achieved.9,24 According to ISO 10993 Part 13 (2010), residual 
monomer is defined as unreacted chemical compound(s) used to build the polymeric 
chains, which is still present in the final polymeric material.11 Three main parameters 
may influence the residual monomer content of a polymer piece: the polymerization 
method, the polymerization cycle and the post-polymerization treatment.9,25 
In terms of the polymerization method, studies have shown that thermo 
polymerizing materials, including heat and microwave cured, present the lowest values 
of unpolymerized residual monomer.9,20,26,27 Koruglu et al. (2012) found lower residual 
monomer values in microwaved resins than in heat polymerizable,28 with the additional 
advantages that the curing cycles are very short and the physical properties are 
comparable to those of conventional heat polymerizable materials.9,29 Conversely, 
autopolymerizable polymers are undoubtedly the materials with the most incomplete 
polymerization reaction, since they present recurrently the highest values of residual 
monomer,20,26 even when compared with light curing materials.27,30 
Ideally, during the thermo-polymerization cycle the increase of the resin internal 
temperature should be controlled in order to avoid the monomer boiling (100,8ºC) and 
the consequent formation of internal porosity, which weakens the polymer structure.12 
A study by Harrison and Huget (1992) showed that the most effective polymerization 
cycle to minimize the residual monomer content was 7 hour incubation in water at 70ºC 
followed by a post polymerization treatment at 1 h at 100ºC.9 Though many authors 
support that longer curing cycles are preferable, Bayraktar et al. (2003) found that long 
curing cycles (9 hours at 70ºC) without post polymerization terminal boil had a higher 
residual monomer content than a shorter cycle followed by a short terminal boil (20 
min. at 70ºC, followed by 22 min. at 100ºC).26 This and other studies show that in order 
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to reduce the final content of residual monomer the most effective procedure is to 
perform a final post polymerization treatment, either a terminal boil, immersion in water 
for at least 24 hours or microwaving for a few minutes.9,20,26,31,32 
Moreover, it has been demonstrated that the reinforcement of acrylic resins with 
fibers of any type contributes to an incomplete polymerization, independent on the 
method or cycle employed.26,28 
Besides, the most appropriate powder/liquid proportion in commercially 
available dental PMMA is 3:1, which limits the volumetric contraction during 
polymerization caused by the monomer, as well as the excess of unpolymerized 
monomer.12 It has been reported that when a material is prepared with a higher 
proportion of polymer (higher ratio), the levels of residual monomer are lower, although 
it may result in a resin too difficult to work with.25 Though as a rule most manufacturers 
respect this proportion, some of them, especially in auto-polymerizable denture and 
orthodontic materials, do not comply with it, increasing the amount of monomer in the 
recommended proportion (about 2.5:1). To illustrate this situation, some examples are 
presented in Table 4, based on the respective manufacturers’ instructions of use. As a 
consequence, this is another factor contributing to the increase in the content of 
residual monomer.25 
One must, however, distinguish between the total residual monomer content, 
which did not polymerize, and the fraction of that monomer which may leach to a 
greater or lesser extent in physiological conditions.33 Therefore, ISO 10993 Part 17 
(2002) considers a leachable substance as any chemical removed from a medical 
device by the action of water or other liquids related to the use of the device.34 Though 
most dental polymers are chemically stable and insoluble, they undergo 
biodegradation, due to the aggressive and complex oral environment, mainly because 
of the permanent contact with water.8,9 As water penetrates the matrix, an expansion 
occurs inside the polymer network, leaching its trapped toxic components such as 
residual monomer and byproducts.8,13,18,19 
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Table 4. Powder/liquid ratios of commercial autopolymerizable acrylic resins 
Commercial Product Manufacturer Powder/Liquid Ratio 
Duraliner II 
(denture) 
Reliance Dental Manufacturing Co., 
Worth, IL, USA 
10 ml : 7 ml 
JET Clássico 
(denture) 
JET, Clássico, São Paulo, Brazil 2.5 : 1 
Kooliner 
(denture) 
GC America Inc., Alsip, Chicago, IL, 
USA 
15 ml : 6 ml 
Poly Seal 
(denture) 
Kamemizu Chemical Ind. Co. Ltd., 
Osaka, Japan 
2 g : 1 ml 
Vertex Self-Curing 
(denture) 
Vertex-Dental B.V., Zeist, The 
Netherlands 
1.7 g : 1 ml (~0.95 g) 
Orthocryl 
(orthodontic) 
Dentaurum GmbH & Co. KG, 
Ispringen, Germany 
2.5 : 1 
Steady Resin M 
(orthodontic) 
Scheu Dental GmbH, Iserlohn, 
Germany 
10 : 5 
 
Furthermore, a study by Danesh et al. showed that there is not a mandatory 
correlation between the monomer leaching characteristics and the residual monomer 
content in a polymer piece.30 This phenomenon may be explained by the nature 
(polarity) and concentration of the solvent, the polymer structure, the size and chemical 
(hydrophilic or hydrophobic) features of the leachable molecules.19,35,36 Moreover, some 
studies have also been pointing out that apart from monomer, other leached toxic 
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substances, such as initiators (BPO, tertiary amines, camphorquinone) and additives 
(HQ, pigments) are released, increasing potential exposure to these potentially harmful 
substances.9,37,38 Many plasticizers derived from phthalate esters (like dibutyl-phthalate 
– DBP) are present in tissue conditioners, hard and soft relining materials and have 
been considered toxic, mutagenic, carcinogenic, teratogenic and xenoestrogenic, 
affecting the reproductive organs and fertility.9,39,40 Moreover, MMA toxic byproducts 
are also released such as methacrylic acid and formaldehyde, which results from MMA 
oxidation.9,18,38,41,42 
Since the residual monomer acts as a plasticizer, many studies have 
established a relation between the degree of conversion and the physical and 
mechanical properties of acrylic resins, like the flexural strength, the hardness, water 
sorption, solubility, dimensional stability, relaxation modulus, transverse strength and 
cubical expansion and specific volume with the temperature.36,43-51 Hence, acrylic 
devices show better mechanical performances if polymerized by methods that increase 
the degree of conversion and reduce the residual monomer content. 
 
 
A.5. Analytical Methods for Residual Monomer Quantification 
 
ISO has been publishing updated international standards that specify which test 
methods and conditions should be employed to appropriately analyze the denture 5 and 
orthodontic 23 polymers’ physical and chemical characteristics. Among other tests, it is 
specified which test methods and conditions shall be used in order to accurately 
measure the total residual monomer content. In general, it is recommended that the 
MMA shall be extracted from the solid polymer with an appropriated organic solvent 
and quantified by means of a chromatographic method, which may be gas 
chromatography (GC), HPLC or another similar chromatographic technique.5,23 The 
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same chromatographic methods are recommended by ISO 10993-13:2010 in order to 
identify and quantify the degradation products from polymeric medical devices, 
including residual monomers, additives and leachables.11 
However, other techniques such as chemical detection, UV and infrared-
spectrophotometry have also been employed to quantify the residual monomer 
content,9,44,45,52,53 and the degree of conversion of carbon-carbon double bonds has 
been measured by the Fourier transform infrared spectroscopy (FTIR).36,54-56 
An accurate residual monomer measurement requires an analytical method 
sufficiently capable of separating, identifying and quantifying the different, but closely 
related, molecules from the multicomponent and complex samples that many times are 
to be analyzed.57,58 
 Generally speaking, in chromatographic techniques the phase that contains the 
sample to be analyzed (mobile phase – MP) is forced through or upon an immiscible 
fixed phase (stationary phase – SP), compelling the sample components to distribute 
themselves distinctly between the two phases. Therefore, if a molecule has more 
affinity to the MP, it will travel faster than one which has more affinity to the SP. 
Consequently, since the migration rates of the substances are different, it becomes 
possible to separate, identify and quantify them.57,58 
 Depending on the physical presentation of the SP, chromatography may be 
classified as planar or columnar. The latter is the most used and consists of a narrow 
tube with an inert porous solid that supports the SP (solid or liquid). Depending on the 
MP physical state, three types are possible: gas (GC), liquid (LC) and supercritical fluid 
chromatography (SFC).58 
Most analytical separations are currently made by LC, due to its sensitivity and 
adaptability, simple automation and wide applicability in science and industry.58 LC has 
the advantages of not destroying the sample and being suitable for nonvolatile 
substances, which cannot be analyzed by GC. Nowadays, the latest LC technology is 
HPLC and is performed using pumping pressures that reach hundreds of atmospheres 
 
24 
inside a thin stainless steel column. Hence, this analytical technique requires 
sophisticated and quite expensive equipment.58 
If the nature of the equilibrium and the separation mechanism are considered, 
chromatography may be classified as: adsorption (liquid-solid), partition (liquid-liquid), 
ion exchange, molecular/size exclusion, affinity and chiral.57,58 Partition 
chromatography (most widely employed in HPLC) varies according to the relative 
polarities of the MP and SP. The first used type was normal-phase chromatography 
(highly polar SP, relatively nonpolar MP), but has more recently been substituted by 
reversed-phase chromatography, where the SP is nonpolar (e.g. hydrocarbon) and the 
MP is polar (water, methanol, acetronitrile, tetrahydrofuran).58 Consequently, the polar 
MP increases the elution time and the most polar molecules eluate first. It has the 
advantage of being possible to use water as a mobile phase (inexpensive, non toxic, 
UV-transparent and compatible with biological solutes) 58 and it is not as sensitive to 
polar impurities.57 
 An HPLC system comprises many devices controlled by a computer which also 
records, analyses and retrieves the results.57 The signal detected by the device at the 
end of the analytical column is processed and the data is plotted as function of time (or 
eluent volume) in a chromatogram. Having in mind that two molecules in a sample 
have different retention rates in the SP and MP (have different distribution constants) 
they are detected at different times, originating two distinct bands or peaks, which 
resemble a Gaussian curve. Thus, the chromatogram gives a qualitative (the time 
position of the peak is characteristic for each molecule at those conditions) and 
quantitative information (the area under the peak) about the sample composition.58 
When performing a HPLC quantitative analysis it is necessary to compare the 
integrated areas under the peaks (preferable to the peak heights) with that of 
previously prepared standards.58 The most direct method is to analyze at least four 
samples of known concentrations of the analyte in the same conditions of the 
subsequent test (the range should cover the concentrations to be determined in the 
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test samples, for higher accuracy). A calibration plot is built using the standards peak 
areas as a function of the known concentrations. The linear zone of the curve (the 
signal given by the detector is proportional to the concentration 57 is used in order to 
interpolate the concentration of the analyte in the test sample from the peak area.58,59 
Nevertheless, if the molecules in a sample are unknown, a HPLC 
chromatogram does not give their identification, but only their retention time in certain 
MP, SP and temperature conditions. Still, if a peak for a determined molecule does not 
appear in the chromatogram it is either absent or its concentration is so low that it is 
bellow the limit of detection (LOD).58 Theoretically, the LOD is the lower analyte 
concentration that produces a signal that is significantly different from the 
blank/background signal. Moreover, the limit of quantification (LOQ) is defined as the 
lower analyte concentration which is possible to determine with precision. Yet, the LOD 
is not the same as the sensitivity of the method, which is numerically equal to the slope 
of the linear zone of the calibration curve. The LOD depends on both the slope and the 
standard deviations (SD) of the points in the calibration curve (blank signal plus three 
SDs of the blank).59 
 
 
A.6. Residual Monomers as Biological Hazards 
 
Stomatitis is a multifactorial oral condition that has been extensively associated 
with PMMA oral devices, particularly dentures, which may be caused or related to poor 
oral hygiene, mechanical trauma, wearing during the night, smoking, systemic and 
nutritional conditions, bacterial and fungal infections, as well as reactions to chemical 
aggressions such as mucosal irritation or allergy by MMA.60-63 Its prevalence has been 
reported between 15 and 70% of denture wearers, with significant variations dependent 
on the sample population, and it is more frequent in elderly people and women.62 
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In patients, diverse systemic reactions to dental acrylic resin have been 
registered such as contact dermatitis and asthma, and local inflammation like lichen 
planus, gingivitis, ulcerations, eczema, erythema, blisters and erosions, papilloma, 
fibroma, and burning mouth sensation, especially on the surface of the mucosal 
prosthetic support and oral adjacent tissues.25,64-68 Despite the cases described in the 
literature,33,63,69-71 genuine acrylic resin contact allergy in patients is a rare condition, 
since the polymerized PMMA is non-sensitizing.33,63,70 Given that polymers are 
macromolecules (molecular weights 5000–1 million), there is not the risk of 
gastrointestinal or dermal absorption and the respiratory tract contact is considered 
negligible.72. However, unpolymerized acrylic monomers in general are capable of 
inducing sensitization and/or irritation and it is widely recognized that professionals in 
the dental area (dentists, dental assistants and technicians and methacrylate 
manufacturing personnel) are commonly affected by allergic contact dermatitis in the 
hands or face, occupational respiratory hypersensitivity and local neurological 
injuries.9,10,49,63,64,70,73 Moreover, clinical gloves only provide limited protection from 
MMA contact.49 
Moreover, some authors have been investigating whether a relationship exists 
between wearing a conventional removable prosthesis and cancer. It has been 
reported that oral lesions caused by chronic trauma and irritation due to ill-fitting 
dentures may lead to an increased risk of cancer in association with other factors such 
as age, smoking, alcohol consumption, poor oral hygiene, defective or missing teeth.74-
76 However, no studies were found trying to establish a relationship between oral 
cancer and MMA aggression. On the other hand, Tomenson et al. (2000, 2005) 
investigated whether an increased prevalence of death caused by respiratory, stomach 
or colo-rectal cancers was related to the occupational exposure to MMA in the 
manufacture of PMMA products.77,78 They came to the conclusion that the cancer 
cases were probably more related to life style habits and so there was little evidence 
that MMA is a human carcinogen.78 
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As formerly mentioned, part of the trapped residual monomer may leach from 
the polymer in clinical conditions and consequently cause biological hazards, such as 
cytotoxicity and genotoxicity.9,18 The smaller molecular monomers are also more 
cytotoxic and there is a direct linear relationship between cytotoxicity and molecular 
hydrophobicity.14,35,79 As referred before, since the lipophilicity relates to the log P, it 
has been hypothesized that the mechanism of the action of monomers is membrane-
mediated and relatively non-specific.14 The hydrophobic molecules interact with the 
phospholipid bilayer of the biologic membranes: cell membrane, endoplasmatic 
reticulum, mitochondrial membrane and nuclear membrane.35,79 
However, the ISO 20795 standard does not cover biocompatibility tests and refers to 
ISO 10993 in order to specify the most appropriate methods to assess possible 
biological or toxicological hazards in medical devices.5,23 Therefore, part 12 of ISO 
10993 specifies the procedures to select and prepare a test sample and to prepare 
extracts from those samples.80 It states that factors like period of extraction, 
temperature, the nature of the vehicle solvent, the type, shape and the phase 
equilibrium of the material and the ratio of surface-area-of-material to volume-of-
extraction solvent should be considered when planning extraction procedures.80 The 
extraction conditions recommended by ISO 10993-12:2007 are summarily presented in 
Table 5. Other parts of ISO 10993 detail how to perform the biocompatibility 
assessment tests, as will be discussed in the next chapter. 
 
 
A.7. In Vitro Biological Assessment Tests 
 
According to ISO 10993 Part 1 (2009) it is important to assess the potential 
biological risks arising from the use of medical devices, within a risk management 
process that includes a review and evaluation of existing data, as well as the selection 
and application of additional tests when necessary.6 Having in mind that denture 
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Table 5. Summary of ISO 10993-12 recommended criteria (conditions and 
procedures) for extraction of leaching residual monomer 80 
Criteria Recommendation 
Thickness >1 mm (larger moulded items) 
Sample dimensions (mm) Indifferent (e.g. T: 10; D: 50/T: 5; D: 25) 
Standard surface area Indifferent 
Solvent volume Indifferent 
Extraction ratio 3 cm2/ml 
Temperature and extraction period: 
37ºC/50ºC – 72h 
Solvent*: polar, non polar, additional 
Temperature and extraction period: 
37ºC – 24h 
Solvent: cell culture media with serum 
Quantification method 11 GC, HPLC, other chromatographic method 
D – Diameter; GC – Gas chromatography; HPLC – High performance liquid chromatography; T – 
Thickness; * More than one option acceptable. Examples of solvents – Polar: water, physiological saline, 
culture media without serum; Non-polar: freshly refined vegetable oil; Additional: ethanol/water; 
ethanol/saline, diluted polyethylene glycol 400, dimethyl sulfoxide, culture media with serum 
 
base polymers may be one of the components of prosthodontic medical devices, it is 
important to perform biological risk assessment tests on them, in order to cautiously 
foresee their behavior during clinical usage. Therefore, the priority of these tests is to 
ensure not only the protection the humans’ health, but also to guarantee animal welfare 
and the minimum of animal testing.6 
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Hence, whenever possible, preference should be given to methodologies that 
simulate and gather likewise relevant information as in vivo models, by performing in 
vitro, ex vivo and analytical chemistry tests. Also, in vitro screening tests should always 
be carried out prior to in vivo assays.6 The major advantages of in vitro biological tests 
is their simplicity, repeatability, reproducibility, controlled environment and are cost-
effective,6,25,81,82 when compared to in vivo tests. 
ISO 10993 describes the guidelines for a wide range of tests including acute 
toxicity, irritation to the skin, eye and mucosal surfaces, haemolysis and 
thrombogenicity, subchronic and chronic toxic effects, sensitization, allergy, 
genotoxicity, carcinogenicity and teratogenicity.6 
 More specifically, cytotoxicity tests use cell cultures to assess several 
endpoints, including qualitative evaluation of cell damage by morphological means 
(apoptosis, membrane and cytoplasm markers), quantify the cell damage and death, 
determine the degree of cell growth and measure the function and cellular 
metabolism.38,83 These tests may be performed using extracts, by direct or indirect 
contact with medical devices or representative parts of them.83 ISO 10993-5:2009 
considers that a test sample has a cytotoxic effect if a 30% reduction in viability 
occurs.83 
Some cytotoxicity test protocols are recommended by ISO, such as neutral red 
uptake (NRU) test, which measures the cells growth inhibition; colony formation test, to 
quantify the cells plating efficiency; XTT ((2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-
[(phenylamino)carbonyl] -2H-tetrazolium hydroxide)) and MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium-bromid) tests measure the cells function and 
metabolism.83 In particular, MTT is a yellow water soluble substance metabolically 
reduced by viable cells into a blue-violet insoluble formazan. The cells viability is 
photometrically determined by measuring the color intensity of dissolved formazan.83 
Other tests that contribute to the direct or indirect assessment of cytotoxicity have also 
been employed, such as 3H-thymidine 68,84 and crystal violet.24 
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 The aim of genotoxicity in vitro tests is to determine to what extent substances 
are capable of inducing genetic damage to mammalian and non-mammalian somatic 
cells, bacteria and yeasts that may be transmitted to the descendent cells.85 Knowing 
that DNA (deoxyribonucleic acid) damage events may trigger or contribute in some way 
to the initiation of a cancer process, it implies that a genotoxic substance may also 
have a potential carcinogenic effect 68,85 that should be further scrutinized in in vivo 
models.85 Since that genotoxicity includes a wide variety of endpoints, more than one 
should be investigated for each candidate test sample. These endpoints include: gene 
or point mutations, small deletions, mitotic recombination, microscopically visible 
changes in the chromosome (or other DNA) structure (clastogenicity) and number 
(aneugenicity).85 Therefore, a battery of in vitro tests should be performed, in order to 
cover separately gene mutations and chromosomal damages.85 ISO 10993-3:2003 
recommends that the OECD (Organization for Economic Co-operation and 
Development) Guideline for the Testing of Chemicals should be followed, in order to 
test for gene mutations in bacteria and gene mutations and clastogenicity in 
mammalian cells.85 Widely published genotoxicity assays for dental materials include 
Ames test on prokaryotic cells such as Salmonella strains 86-88 and the bacterial umu-
test;89 for mammalian cells: the single cell microgel electrophoresis (Comet assay),90,91 
hprt gene mutation,92,93 chromosome aberration (CA) 68 and sister-chromatid exchange 
(SCE) assays 68 and the in vitro micronuclei test (MNvit).24,94-97 
 
 
A.8. Cell Cultures for In Vitro Biological Testing 
 
One of the most employed and profitable methods of running in vitro biological 
assays is to grow eukaryotic cells outside the living organism or tissue in the laboratory 
environment – cell culture 82–, providing a more convenient and homogeneous 
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population of cells to test and manipulate.98 Moreover, a large amount of cells can be 
obtained; it is possible to isolate a single cell type from a complex tissue or to explore 
the interactions between two cell types; cells are able to multiply and differentiate; 
since that many cells’ properties and functions are maintained in culture; the cellular 
activities may be deeply studied and it is possible to test the cells response when 
challenged by drugs, hormones, growth factors and other molecules.82,98 
 Because eukaryotic cells cannot live in fluid suspension like bacteria and 
yeasts, they are seeded in appropriated culture vessels, including glass petri dishes, 
plastic culture flasks or plastic multiwells and microtitre plates, with a surface treatment 
(polylysine or extracellular matrix components), to which they can attach, forming a 
monolayer, in order to grow and divide.83,98,99 Besides, the culture dish must contain a 
rich nutrient media, implying that the manipulation must occur in sterile conditions in 
order to avoid contamination by bacteria and fungi.82,99 Besides, in order to prevent 
contamination, cell culture medium includes large spectrum antibiotic and 
antifungal.82,83 In 1955, Eagle revolutionized the animal cell culture science, by 
determining the necessary ingredients of culture medium, which included salts, 
glucose, amino acids, vitamins, and natural animal serum with polypeptide growth 
factors that are important for the stimulation and regulation of the cell cycle.99,100 
Nowadays, it is possible to grow cells using entirely synthetic medium, containing 
variable proportions of nutrients, vitamins, proteins such as insulin and epidermal 
growth factor, and transferring.82 
 In relation to the source of the culture cells, if they are collected directly from a 
tissue or organ (generally embryonic, but also adult) they are called primary 
cultures.82,98,99 In average, animal cells take approximately 20 hours to complete a cell 
cycle and divide in optimal conditions.99 When they are almost covering the surface of 
the culture plate (80% subconfluent, corresponding to the end of the logarithmic phase 
of growth) they are treated with trypsin (proteolitic enzyme) to digest the extracellular 
adhesions to the dish and a Ca2+ chelanting substance, such as EDTA 
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(ethylenediamine tetraacetic acid).82,83,98 Cells are replated on new dishes with lower 
density, and this process is consecutively repeated (passages) originating secondary 
cultures.98,99 Many times, secondary culture cells are acquired in frozen vials (for 
conservation during months or years in liquid nitrogen at -196ºC), which recover their 
activity upon thawing.82,83,98  
However, secondary cells from normal tissue have a limited life span and 
cannot be passaged infinitely, because eventually they enter in a process of replicative 
cell senescence and stop dividing.98,101 These culture populations can only be doubled 
typically 50 to 100 times, depending on the cell type.82,99 Moreover, their phenotype 
begins to change with increasing number of passages 101 and factors such as age, 
metabolic and hormonal conditions of the donor may influence primary cell cultures.68 
In order to solve these problems, genetic modifications are induced, allowing 
the cells indefinite division, becoming immortal/permanent cell lines.82,99 The so-called 
transformed cell lines, derived from malignant tumors, grow rapidly and proliferate to a 
high density,98 have good reproducibility and are genetically and metabolically stable.14 
Embryonic stem cells also share these properties and are capable of differentiating into 
any type of adult cell.99 Still, cell lines usually show significant differences in their 
activity from their respective progenitor tissues 98 and there is a certain concern that 
many cell lines present mutant genes capable of disrupting the process of apoptosis, 
influencing the cell death.14 
 Cell types derived from malignant tumors are the most widely used in laboratory 
experiments such as fibroblasts (e.g. mouse – 3T3), epithelial cells (e.g. human – 
HeLa), ovary cells (e.g. chinese hamster – CHO), myoblasts, chromaffin cells, plasma 
cells, kidney and macrophages.98 ISO 10993 Part 5 (2009) recommends (for 
cytotoxicity testing) the employment of established cell lines from recognized 
repositories, though primary cell cultures shall be used for specific sensitivity 
requirements, if their accurate and repeatable response is demonstrated.83 Some of the 
recommended cell lines are L929 (mouse fibroblasts), 3T3, WI-38 (human fetal lung 
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fibroblast) and V79-379A (chinese hamster lung fibroblast).83 When it comes to testing 
the biological activity of monomers such as MMA, the cell types that have been 
employed are immortalized cell lines like V79-B,24,93 L929,32,102 CHO 68 and HSG 
(human submandibular gland adenocarcinoma),35,79 primary cells from human biopsies 
or tooth extractions like HGF (human gingival fibroblasts),14,35,79 PDL fibroblasts 
(human periodontal ligament),14 CPC (bovine dental papilla).101 
 
 
A.9. Cell Cycle and Mitosis Overview 
 
 The cell cycle comprises a series of complex, coordinated and controlled 
processes that are fundamental for the continuation of life, through the growth and 
division of both prokaryotic and eukaryotic cells.99 Cells’ self-reproduction is essential 
for the proliferation of unicellular species and for the maintenance of multi-cellular 
organisms.103 
 The major stages of the eukaryotic cell cycle are the interphase and M phase, 
which are subsequently divided in substages. Once the cell decides to go forward with 
the cell cycle, there is no turning back to the previous stage.103 
The interphase is the period between the cells divisions and may last for days, 
weeks or years, depending on the cell type and on the environment conditions.82 
During the first substage of interphase, G1, the cell has the opportunity to grow, to 
exert its metabolic functions, to interact with and evaluate the surrounding environment, 
to differentiate and to duplicate its organelles.82,103 If the cell is not stimulated, it may 
enter a G0 period (quiescence), continuing with its metabolic functions, but not 
growing. If the cell receives an external stimulus such as growth factors, it is induced to 
begin proliferation, thus surpassing the restriction point, which commits the cell to enter 
and finish the division process.99,103 
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Next, the S (synthesis) phase is a critical moment, when the cell carefully 
replicates its DNA, duplicating its genome.82 The cell possesses several specific 
mechanisms (checkpoints) to regulate and correct the DNA replication. Protein kinases 
ATM and ATR become activated with DNA incorrect replication and activate other 
enzymes such as Chk1, Chk2 and p53 (very often mutated in cancer cells) that stop 
the cell cycle progression, in order to gain time for DNA reparation.99,103 Mechanisms 
such as proofreading (DNA polymerase) and mismatch repair correct the mistakes 
resulting from an erroneous base pairing and therefore avoid that incorrect genomic 
information (e.g. mutations, DNA double stranded breaks) is transmitted to the 
daughter cells.103 The next step is called G2, when the cell is preparing to actually start 
the division if everything is under control. A G2 checkpoint arrests the cell cycle if 
unreplicated or damaged DNA is detected.99 
The M phase is subdivided in mitosis, which in turn has its own substages, and 
cytokinesis, comprising the cell division itself. During the first mitosis substage, 
prophase, DNA condensates and the chromosomes become more compact. The two 
equal chromosomes that result from replication are paired (sister chromatids), united 
by a specific DNA sequence, the centromere, with bonded proteins, forming the 
kinetochore.82,99 The cytoskeleton disassembles and the centrosomes travel in 
opposite directions towards the cell poles to start forming the mitotic spindle.99,103 
When the dissolution of nuclear envelope begins, the cell enters the 
promethaphase stage. Chromosomal condensation continues and the actin 
microtubules attach to the paired chromosomes kinetochore.82,99,103 At this moment, the 
spindle assembly checkpoint (SAC) verify if all chromosomes were correctly connected 
to the respective microtubule.103 If not, the chromosomes risk not being segregated to 
the daughter cells and are left behind (lagging chromosome).82 
During the next step, metaphase, the dichromatids finish condensation and 
align their kinotochores in the equatorial zone of the cell.103 In this stage, the 
microtubules of the mitotic spindle are functionally differentiated into three types: astral 
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microtubules (help with the correct positioning of the spindle apparatus), 
chromosomal/kinetochore microtubules (connect the centrosome to the kinetochores 
and exert a pulling force toward the poles) and polar/interpolar microtubules (extend 
from one centrosome to the other past the chromosomes and maintain the integrity of 
the whole apparatus).82 
 During the transition from metaphase to anaphase, an anaphase promoting 
complex (APC) is activated and an enzymatic complex destroys the proteins (securins) 
responsible for the maintenance of the kinetocore.82 Consequently, at the anaphase, 
segregation occurs with the dissolution of the centromere, separating the sister 
chromatids (anaphase A), which migrate in opposite directions pulled by the 
microtubules (anaphase B). The cell becomes longer because of this movement, 
increasing the distance between the centrosomes.103 
 The last stage of mitosis, telophase, is characterized by the decondensation of 
the chromosomes that become indistinguishable again. The nuclear envelope is 
reorganized, involving the genetic material of each potential daughter cell. The mitotic 
spindle disassembles and the organelles are equally distributed through the two 
daughter cells.103 
 In the last part of the M phase of the cell cycle, cytokinesis, the cytoplasm is 
divided by the formation of a contractile ring (actin and myosine filaments) that 
cleavages the cytoplasmic membrane.82,103 It has been reported that the place where 
the contractile ring is positioned matches the zone once occupied by the aligned 
chromosomes during methaphase.82,103 
Ideally, two similar daughter cells, with the same genetic material, should form 
upon the end of cytokinesis. However, despite the numerous checkpoints and repairing 
mechanisms, failure in the mitotic process may occur for various reasons. Some of 
these factors will be further discussed in the next chapter. 
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A.10. In Vitro Mammalian Cell Micronucleus Test 
 
 Ever since Boveri a hundred years ago, it has been described that disturbances 
during the chromosome segregation in mitosis may cause cancer and that many 
cancer cells present several nuclear morphological abnormalities.104,105 Later, 
haematologists described the Howel-Jolly bodies, firstly identified in bone marrow 
dividing erythrocytes, associated with the lack of vitamin B12 and folate.105,106 Since the 
1980s that these cellular bodies are known as micronuclei (MN), which represent the 
damage that has been transmitted by an affected mother cell through a genotoxic 
agent or event to the daughter cells.107,108 In 1997 the International Human 
Micronucleus (HUMN) Project was founded to coordinate investigation groups all 
around the world that dedicated to research on micronuclei with human lymphocytes as 
a tool for studying the DNA damage in human populations.108 
Most MN are originated by an acentric chromosome or chromatid fragment or 
even a whole chromosome that is left behind (lagging chromossome) during the 
anaphase and can be observed in interphasic cells as a smaller additional 
nucleus.105,107,109 It may be caused by a chromosome breakage or by a dysfunction in 
the mitotic system.105,110 Since lagging chromosomes are detached from the mitotic 
spindle, they cannot travel into the direction of the poles in order to incorporate the new 
nucleus.105,110 This lost genetic material is eventually enclosed by a nuclear membrane 
and is completely separated from the main nucleus, showing similar morphological 
features to the latter, except for the size that is quite smaller.105 So being, the MN 
formation leads to the loss of genetic material by the micronucleated daughter cell.110 
Morphologically, MN show the following characteristics: the diameter of MN ranges 
1/16th to 1/3rd of the mean diameter of the main nucleus or 1/256th to 1/9th of the area; 
MN are non-refractile, thus are not confoundable with artifacts resulting from the 
preparation; MN are not linked to the main nucleus, though they may be touching, but 
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not overlapping; the stain intensity of the MN is similar to the nucleus, though it may be 
slightly more intense.106 
MN may also originate from fragments of broken anaphase bridges during 
chromosome rearrangements (e.g. dicentric chromatids, intermingled ring 
chromosomes or union of sister chromatids).110 In these cases it may occur the 
formation of a nucleoplasmic bridge (NPB), surrounded by the nuclear membrane, 
which also represents a genetic defect and may lead to the occurrence of MN as 
well.105,111 Another nuclear anomaly, the nuclear bud (NBUD), has a similar morphology 
to the MN, but it is still connected to the main nucleus. Under certain circumstances, 
too much DNA amplification occurs and the excess of genetic material concentrates at 
the periphery of the nucleus to be expelled during the S phase, thus forming the 
NBUD.105,111 It may also be the product of the elimination of DNA repair complexes and 
excess of chromosomes in aneuploid cells.105 In some situations the NBUD may be a 
precursor of MN.105 
The causative agents of MN may be physical agents (ionizing radiation), 
oxidative stress, clastogen or aneugen agents, mutations in cell-cycle checkpoints or 
DNA repair mechanisms and nutritional deficiencies, such as folate and other co-
factors, which are essential for DNA metabolism and mitosis.106,112 These factors are 
capable of interacting with nuclear DNA and producing major genetic alterations in 
eukaryotic cells.106 Therefore, MN (as well as NPB and NBUD) are not only important 
for biological risk assessment of genotoxic agents, but also as objective biomarkers of 
chromosomal instability, since it has been observed that malignant cells, cells with 
defects in the DNA repair system or impaired cell cycle checkpoints, present higher 
scores of MN.105,113 
 It took approximately 20 years for the in vitro mammalian cell micronucleus 
(MNvit) test to become accepted by the OECD as a reliable test method for the 
assessment of chromosomal damage, with the publishing of the OECD 487 guideline in 
July 2010.114 This assay is not yet recommended by ISO 10993 Part 3, since this 
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standard was published some years earlier. The MNvit test allows the evaluation of the 
genotoxicity (objective observation of chromosomal aberrations) activity of chemicals 
and also assesses the cytotoxic effect of the tested material (as cell viability and 
proliferation).107,109 The MNvit test is a robust effective and relatively accessible 
method, which can be applied to a great variety of cells,107 though most studies have 
been performed in human peripheral blood lymphocytes 110 and rodent cell lines like 
CHO and V79, which are fully validated.107 Moreover, when comparing with other 
methods such as chromosomal aberrations, it has shown to be simpler to perform, 
easier to learn how to count, time-effective, allowing the quantification of cells in the 
range of thousands, which increases its statistical sensitivity and has the possibility of 
becoming automated.24,107,110,111 MNvit test has also evolved into a “cytome” method, 
since it is possible to use it as a biomarker to monitor chromosomal instability caused 
by genetic defects and/or external factors,112 it is a multi-target genotoxic endpoint, 
predictive for in vivo genotoxicity and cancer in humans and allows extrapolation to 
potential limits of exposure or thresholds.114 Moreover, it enables the assessment of 
other cellular events such as the mitotic rate, cell death (apoptosis and necrosis) in the 
same assay.106,111 
 The OECD 487 MNvit protocol requires that upon cells contact with the test 
substance, they should undergo a whole cell cycle, i.e. mitosis must occur so that 
damage is eventually induced on the chromosomes or mitotic spindle that leads to MN 
formation.106,107 Since MN scoring is only valid for cells that completed mitosis during or 
after exposure to the test agent, one possibility is to employ a cytokinesis blocker (the 
most widely employed is the cytokinesis-block micronucleus (CBMN) assay, using an 
actin polymerisation inhibitor like cytochalasin B (CytoB) 3-6 μg/ml), leading to the 
formation of binucleated cells, clearly distinguishable from interphase cells.106,107 In this 
case MN frequencies should be scored in at least 2000 binucleated cells per test 
concentration (if two replicas are used, then 1000 per culture).106,107 Binucleated cells 
with irregular shapes, with more than two nuclei or with nuclei too divergent in size 
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should not be counted 106,107 However, it is possible as well to perform the MNvit test 
without employing a cytokinesis blocker, since that it has been assured that cells to be 
counted have undergone mitosis during or after the agent exposure, in order to avoid 
false positive results.107 In this case, at least 2000 mononuclear cells per replica should 
be assessed.107 Moreover, Parry et al. (2010) do not require the CBMN assay as a 
minimal performance criterion for MNvit, recommending it as a sensitive complement to 
detect some aneugens.114 
 Furthermore, the extent of cytotoxicity or cytostasis of the test agent should be 
assessed for that specific cell culture prior to the MNvit test, in order to determine the 
highest concentration of the test substance to be employed.107 It is very important to 
avoid artifactual positive responses caused by excess of cytotoxicty, precipitation in the 
medium and changes in pH or osmolality.107 Al least three test concentrations should 
be tested per chemical,107 from little to no cytotoxic effect to the highest concentration 
tested that should not exceed 55 ± 5% cytotoxicity.107 The OECD 487 protocol, also 
recommends that test procedures should be performed with and without an exogenous 
metabolic activation with post-mitochondrial S9 fraction from rat liver, since that some 
cell types have inadequate endogenous metabolic capacity.107 
 Untreated cultures should be employed as negative controls and give 
reproducible low and consistent MN counts. The cell types above mentioned typically 
show 5-25 cells with MN/1000 cells, though the counts for other cell types might be 
different.107 Moreover, known inducers of small, but reproducible increases in MN 
formation (when compared with the negative control) should always be employed as 
positive controls in order to assess the efficiency and sensitivity of the test protocol and 
cell model used.107 
 In terms of results assessment, slides may be observed at the light microscope 
using the Romanowsky/Giemsa/Diff Quick stain 106,107,115-118 or at the fluorescence 
microscope, using fluorescent DNA specific stains such as acridine orange,119 Hoechst 
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33258 plus pyronin-Y,107 Schiff/Feulgen reagent 24,94,108 and propidium iodide (PI).120 
Some artifacts may be produced by not employing specific-DNA stains.107,121 
 One of the main advantages of the MNvit test is its ability to detect clastogenic 
(structural chromosome alterations) and aneugenic effects (numerical chromosome 
alterations).110 However the MNvit test alone cannot distinguish between these two 
types of defects,107 though this is an important information when screening chemicals 
and characterizing their genotoxic profile.122 Moreover, the existence of a threshold has 
been suggested for aneugenic MN, since that spindle poisons do not interact directly 
with the DNA, but only with the mitotic apparatus.122,123 Hence, aneugenic chemicals 
only show adverse effects upon a certain exposure level, representing a minimal 
biological risk after human exposure.122,123 On the other hand, clastogens, including 
ionizing radiation, topoisomerase II inhibitors, inducers of reactive oxygen species 
(ROS) and alkylating agents, interfere directly with the DNA sequence and a threshold 
dose-effect relationship is not well established yet.123 Therefore it is important to resort 
to immunofluorescence staining or fluorescence in situ hybridization (FISH), with DNA 
probes for human α-satellite DNA, to determine whether kinetochore proteins or 
centromeric DNA are present or absent inside the MN.107,110,122 Since that acentric 
fragments do not contain centromeres nor kinetochores (clastogenic MN), if these are 
present then it confirms that it is an aneugenic MN.107,110,122 However, this method is 
only well validated for human and V79 cell lines, since it is more difficult to get 
appropriate DNA probes for other cell types. Moreover, the FISH method implies the 
repetition of the slide preparation procedure, is time consuming and expensive.122 
Therefore, Hashimoto et al. (2010) proposed a new method to distinguish between 
aneugenic and clastogenic MN, by size-classifying them. MN showing less than ¼ the 
diameter of the main nuclei were considered clastogenic and those between ¼ to ½ the 
diameter of the main nuclei were aneugenic. Then they compared the sensitivity of this 
method with the traditional FISH procedure on chinese hamster lung fibroblasts to a 
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variety of chemicals and concluded that it was comparably reliable, quicker and 
simpler.122 
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B. JUSTIFICATION  
AND OBJECTIVES 
 
 
 
 
43 
A heat polymerizable denture base polymer (Type 1, Class 1) was selected as a 
test material since it is still widely employed mainly in the fabrication of dentures (either 
conventional of implant-supported removable of fixed, total or partial), which usually are 
used by the patients many hours per day for years or even decades. Moreover, these 
devices must be manufactured in such a way that there is as much base surface area 
as possible in close contact with the patient’s oral mucosa (the palate and/or the 
gingiva). As stated previously, these materials have been constantly associated with 
allergic reactions and contact irritations. Therefore, it may be hypothesized that the 
chronic use of these devices, may lead to chronic damage to the oral tissues nearby. 
Appropriate in vitro cytotoxicity and, eventually, genotoxicity testing of dental 
polymers is fundamental to establish the limits for clinical safety, requiring suitable cell 
models that closely simulate oral processes. Mammalian non-oral chinese hamster 
lung fibroblasts lines (V79) have been extensively used with this purpose, but to date, 
no in vitro studies were made concerning the objective quantification and relationship 
between acrylic resin residual monomer (MMA) leaching (in conditions comparable to 
routine clinical situations) and genotoxicity in an untransformed human gingival 
fibroblastic (HGF) cell line.  
The main objectives of this research are to: 
1. Quantify the MMA monomer concentration leached into artificial saliva from 
heat polymerizable denture base polymer pieces; 
2. Characterize a human gingival fibroblast (HGF) line as an oral cell model for 
cyto and genotoxic testing;  
3. Evaluate the cytotoxicity and genotoxicity effects in oral cells (gingival 
fibroblasts) leached residual monomer; 
4. Optimize suitable techniques for the quantification of residual monomer. 
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C. MATERIALS 
AND METHODS 
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C.1. Acrylic Resin Sample Preparation: General Procedures 
 
The characteristics of the acrylic resin used in this study are summarized in 
Table 6. The samples were produced by conventional prosthetic methods, respecting 
the manufacturer’s instructions of use.  
 
Table 6. Characterization of the denture acrylic resin tested (according to the manufacturer) 
Products 
Batch 
no. 
Composition Manufacturer 
Powder/ 
Liquid 
Ratio 
Standard 
polymerization 
cycle and cooling 
Residual 
monomer 
ProBase 
Hot 
Polymer 
(pink) 
P49030 
PMMA, 
plasticizer, 
pigments, 
BPO (< 1%) 
Ivoclar 
Vivadent AG, 
Schaan, 
Liechtenstein 
Powder: 
22.5 g 
Liquid: 
10 ml 
Start with cold 
water. Heat up to 
100ºC and let 
boil for 45 min. 
Cool at room 
temp. for 30 min 
and then with 
cold water. 
< 2.2% 
(after 
standard 
polymeri-
zation 
cycle) 
ProBase 
Hot 
Monomer 
P46582 
MMA (50-
100%), 
EGDMA 
(2.5-10%) 
 
Wax discs (1.5 mm height x 15 mm diameter) were cut manually from height 
calibrated 1.5 mm wax sheets (Anutex Toughened Wax, Kemdent, Purton, United 
Kingdom) using a metallic circular punch tool (Korff & Honsberg, Remscheid, 
Germany) with 15 mm of diameter. Each two discs were lightly heated and attached in 
order to produce single wax pieces measuring 3.0 ± 0.1 mm thick (using a manual 
thickness gauge) and 15.0 ± 0.1 mm of diameter (using a manual calliper). The best 
wax pieces were selected and mounted carefully to avoid air bubbles in type IV 
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gypsum (GC Fujirock EP, GC Ibérica, Madrid, Spain) inside one half of a conventional 
denture flask (Figure 2). The hardened gypsum was isolated with separating fluid 
(Ivoclar Vivadent AG, Schaan, Liechtenstein) and the other half of the flask was filled 
carefully with gypsum upon the wax discs. The flask was covered, put on a metallic 
press to remove the gypsum excesses and let harden. Afterwards, the ready closed 
flasks were immersed with the metallic press in boiling water for 5 minutes in order to 
eliminate the wax patterns. The flasks were opened and the wax rests were further 
washed with boiling water. According to the manufacturer instructions, both hot wet 
gypsum halves were isolated with 2 layers of separating fluid (Figure 3) 
 
 
 
 
 
 
 
 
 
 
 
 
The polymer powder was weighted on a semi-analytic balance (Kern 440-33N, 
Kern&Sohn GmbH, Balingen, Germany) and the volume of monomer liquid was 
measured in a 10 ml glass graduated cylinder, according to the manufacturer 22.5 g : 
10 ml mixing ratio. The two compounds were thoroughly mixed with a metallic spatula 
in a glass container and the resulting mass was left to mature in the closed container at 
room temperature for 8 to 10 minutes, until it did not stick to the fingers. The process of 
covering all patterns in the gypsum with the mass took no longer than 20 minutes 
Fig. 2 – 3.0 x 15.0 mm wax patterns mounted 
in gypsum inside a conventional denture flask 
Fig. 3 – Gypsum isolation with separating fluid 
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(Figure 4). Each flask was closed and loaded for approximately 5 minutes with 80 bar 
of pressure in a hydraulic press (Figure 5). Hereafter, the flasks were carried in pairs in 
the metallic press and completely immersed in cold water. The standard polymerization 
cycle recommended by the manufacturer was followed, as well as the gradual cooling 
procedure, as described in Table 6. In the end, each flask was opened and the gypsum 
was broke to liberate the resin discs.  
 
 
 
 
 
 
 
 
 
 
 
Since the manufacturer instructions of use did not specify the polishing 
procedure, the recommendations in the standard ISO 20795-1:2008 (section 8.8 – Test 
methods: Residual methyl methacrylate monomer) polishing method were followed. 
After the polymerization cycle was concluded, the discs were kept in a dark and dry 
place for 24 ± 5 hours at room temperature. The acrylic excesses and surface major 
irregularities were wet trimmed with a carbide bur at low speed. Afterwards, each disc 
was polished equally in both sides with a wet P 100 metallographic grinding paper 
(Klingspor AG, Haiger, Germany). Besides, both sides were wet polished with P 600 
and P 1200 grinding impermeable papers (Klingspor AG) until the surface was smooth 
Fig. 4 – Covering of patterns with the polymer 
mass 
Fig. 5 – Flask loaded at 80 bar in hydraulic 
press 
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and had minimal porosity at visual inspection. The periphery was also slightly wet 
abraded with the P 1200 grain paper.  
In the end, an average of 3.0 mm height should be achieved in 3 different points 
of the discs measured with a manual thickness gauge. The 15 mm diameter was also 
verified using a manual caliper, each piece was weighted 3 times with an analytical 
balance (Kern 770-13, Kern&Sohn GmbH, Balingen, Germany) and all of these values 
were recorded for specimens’ quality control. All specimens were kept in the dark at 
room temperature for approximately 24 hours before testing. 
 
 
C.2. Extraction of the Leachable Residual Monomer 
 
The extraction conditions and methods were based in ISO 10993-12:2007 
recommendations.80 Therefore, the standard surface area, which includes both sides of 
the sample and excludes minor irregularities, was used to determine the volume of 
extraction vehicle needed. ISO 10993-12:2007 rules that for larger moulded items with 
a thickness > 1.0 mm, the extraction ratio ± 10% (surface area/volume) is 3 cm2/ml. 
Thus, the surface area of the discs was approximately 4.95 cm2, corresponding to a 
vehicle volume of 1.65 ml, which was added with a micropipette to separate sterilized 
and light proof glass containers (Figure 6). 
In order to simulate the oral conditions the polar extraction vehicle chosen was 
artificial saliva. Since in the published literature there are no consensual formulas for 
artificial saliva, this study followed the pre-standard DIN (Deutsches Institut für 
Normung) 53160-1:2002 (Table 7).124 The solution was prepared in advance with 
sterilized distilled water and the pH was stabilized in the range of 6.8 ± 0.1. The 
solution was filtered with a 0.2 µm pore syringe filter (Puradisc 30, Whatman, GE 
Healthcare, Buckinghamshire, United Kingdom) and subsequently distributed in 10 ml 
aliquots, which were fronzen at -20ºC until use.  
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Fig. 6 – Acrylic resin sample submersed in artificial saliva inside a glass container (not opacified yet) 
 
ISO 10993-12:2007 establishes that an appropriate exaggeration of the product 
use shall be conducted. Therefore, at 37ºC, discs (n = 6) (polished according to the 
standard ISO 20795-1:2008) were incubated in artificial saliva for 72 ± 2 hours. 
Negative controls of artificial saliva were also incubated for comparison. The containers 
were closed with the respective cover and stored in an incubator (IKA KS 4000 ic 
control, IKA® Werke GmbH & Co. KG, Staufen, Germany) with continuous agitation at 
40 rpm.  
In the end of each test period, the discs were collected with a sterile tweezers 
and the extraction samples inside the containers were frozen until the leached 
monomer analysis was performed.  
 
  
 
50 
Table 7. Artificial saliva formula (DIN 53160-1:2002) 124 
Reagents Mass concentration (g/L) 
Magnesium chloride – MgCl2.6H2O  0.17 
Calcium chloride – CaCl2.2H2O  0.15 
Dipotassium hydrogen phosphate – K2HPO4.2H2O 0.76 
Potassium carbonate – K2CO3  0.53 
Sodium chloride – NaCl  0.33 
Potassium chloride – KCl  0.75 
1% (m/m) Hydrochloric acid – added until the pH value 6.8 ± 0.1 is achieved. 
All reagents are from Sigma-Aldrich (St. Louis, MO, USA) 
 
 
C.3. HPLC Quantification of Leachable Residual Monomer 
 
The analytical procedures described in this section were optimized and 
performed by the Laboratory of Applied Chemistry, Department of Chemistry-Physics, 
Faculty of Pharmacy of the University of Porto, Portugal. It was based on HPLC 
determination according to ISO 20795-1:2008 Annex A, but improved relatively to the 
method detection limit (MDL) and method quantification limit (MQL) by resorting to 
microextraction techniques.  
Calibration solutions with known MMA concentrations ranging from 70 ppb to 14 
ppm were prepared from pure MMA (99,4%, Sigma-Aldrich) in artificial saliva 
(composition in Table 7).  
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For the analysis, 1200 µl of each standard sample solution were transferred to 
1500 µl microcentrifuge tubes and kept in ice during 10 minutes. Afterwards, 60 µl of 1-
octanol were added and the mixtures were vortexed at 15 Hz for 20 seconds. Then, 
centrifugation was performed at 4000 rpm during 5 minutes, in refrigerated atmosphere 
(4ºC). The aqueous phase present in the bottom of the tube was removed and rejected 
with the help of a chromatographic syringe. The organic phase was injected directly in 
the chromatographic loop. 
The chromatographic separation was performed using a Merck Hitachi LC 
system (Ltd. Tokyo, Japan), equipped with a LC pump L-7100, an interface D-7000 and 
a Diode Array Detector. A C18 column (Waters, Spherisorb ODS2, pore size 5 µm, 4.6 
x 250 mm, Dublin, Ireland) with a security guard cartridge (4.0 x 3.0 mm, Phenomenex, 
USA) was used. An isocratic elution at 0.8 ml min-1 was performed using as MP 
methanol (MeOH) and water in a mixture 70:30 (v/v). The injection volume into the loop 
was 20 μl and the analysis was carried at room temperature (20 ± 1ºC). 
Chromatography Data Station Software was used for control and data processing. 
Spectrophotometric detection was carried out with a wavelength of 205 nm. Using the 
described experimental conditions, MMA monomers retention time was 5.20 minutes. 
MMA concentration in the artificial saliva solution was determined by interpolation using 
the calibration curve (y = 4.03x10-8  x + 150000). 
 
 
C.4. Cell Culture Preparation and Maintenance 
 
An untransformed human gingival fibroblast (HGF) commercial cell line 
(AG09429, Coriell Cell Repository, Camden, NJ, USA) was chosen as the main study 
model. Additionally, two other cell types were included in this study as control cell 
types: a chinese hamster lung fibroblast cell line (V79-4) (603371, CLS - Cell Lines 
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Service, Eppelheim, Germany) and an untransformed human fetal lung fibroblast cell 
line (WI-38) (90020107, Sigma).  
Every procedure with cell cultures were performed at the Laboratory of 
Pharmacology and Biocompatibility of the Faculty of Dental Medicine of the University 
of Porto, Portugal. All cell cultures were acquired in cryovials and were unfroze and 
seeded in a sterile environment (inside a laminar flow cabinet) in 9 cm of diameter 
tissue culture plates (Orange Scientifique, Braine-l’Alleud, Belgium) with 10 ml of 
complete α-MEM (Table 8) at a concentration of 6x104 cells/plate and incubated in a 
humidified atmosphere of 95% air and 5% CO2 at 37ºC. The culture medium was 
replaced 2 to 3 times a week.  
The cells were removed from the culture plates by enzymatic digestion with 
0.05% trypsin (Sigma) in 0.25% EDTA (Sigma) (10 minutes in humidified atmosphere 
of 95% air and 5% CO2 at 37ºC) to detach adherent cells, when the monolayer cultures 
were 70-80% confluent, and were subsequently seeded at 6 x 104 cell/ml in 9 cm of 
diameter Petri plates.125 HGF and WI-38 complete their cell cycles in about 24 hours, 
while V79-4 cells take only 12 hours. HGF and WI-38 cells took approximately 6-7 days 
to grow, while V79-4 cells were trypsinized in 3-4 days. The cultures were amplified 
and a few aliquots of each cell types were stored at -80ºC (if for only a few months) or -
196ºC (if for several months) at a concentration of 2x106 cell/ml in an appropriate 
medium composition with a cryoprotectant (45% α-minimal essential medium (α-MEM); 
45% fetal bovine serum (FBS); 10% dimethyl sulfoxide (DMSO, Panreac Quimica, 
Barcelona, Spain)) 
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Table 8. Complete cell culture medium (complete α-MEM) formula* 125 
Reagents Concentration 
α-minimal essential medium (α-MEM, Gibco) 86% v/v 
Fetal bovine serum (FBS; Gibco/BRL) 10% v/v 
Ascorbic acid (Sigma) 50 μg/mL 
Penicillin/Streptomycin (Gibco) 100 IU/mL/10 g/mL 
Amphotericin B (Fungizone, Gibco) 2.5 μg/mL 
Glutamate (Sigma) 1% v/v 
* Prepared fresh before use. Stored at 4ºC for no longer than 3 days. 
 
 
C.5. Cytotoxicity Test 
  
MTT was the cytotoxicity test chosen and it was performed having in mind the 
general guidelines given in the Annex C of ISO 10993-5:2009.83 Each experiment was 
performed 3 times. At least two passages after the cultures were unfroze and during 
the exponential growth phase, the 3 cell types were seeded in 96-well plates (Orange 
Scientifique) in 100 µl of complete α-MEM with a cell suspension of 1x105 cells/ml 
(1x104 cells/well). According to the ISO recommendations, the cells were incubated for 
24 hours in standard conditions before testing, in order to ensure that cells had time to 
adhere, return to their exponential growth phase and form a semi-confluent monolayer. 
Besides, the wells were observed at the inverted microscope (40x magnification) 
(Nikon TMS-F, Nikon, Japan) to confirm if the cultures growth was similar in all plates.  
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 Just before the cytotoxicity testing started, the toxic agents were diluted in fresh 
complete cell medium, according to the conditions listed in Table 9. The initial culture 
medium was aspirated from the wells and replaced by 100 µl of treatment medium. The 
cells were incubated for another 24 hours in standard conditions. 
 
Table 9. Experimental conditions of the cytotoxicity tests (MTT) 
Experiment Cells Toxic agent Manufacturer Concentration (n = 6) 
1 
2 
3 
HGF 
V79-4 
WI-38 
Control (-) _ 0 
EMS (µg/ml) 
Sigma-Aldrich 
600 1200 2400 
MMA (mM) 40 80 160 
Formaldehyde (µM) 400 800 1600 
EMS – Ethyl methanesulfonate; MMA – Methyl methacrylate 
 
 Later on, the cultures were observed in the microscope in order to register the 
morphological alterations that occurred due to the toxic agents and to confirm the cell 
density in each well. Subsequently, 10 µl of the MTT solution (0.5 mg/mL; Sigma) was 
added to each well and the plates were incubated for 3-4 hours in standard conditions. 
Then, the culture medium was removed and the toxic waste was collected to separate 
recipients. 100 µl of DMSO were added to each well, even as two blanks of DMSO in 
each plate, and the plates were agitated for 5 minutes before being introduced in a 
microplate reader (Synergy HT, BioTek Instruments, Winoosky, VT, USA).  
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C.6. Genotoxicity Test 
 
 Based on the HPLC monomer quantification and cytotoxicity tests results, the in 
vitro mammalian cell micronucleus test was performed only for HGF and V79-4 cell 
lines, following the OECD 487 guideline for the testing of chemicals.107 2 separate 
experiments (A and B) were performed for each test group. No cytokinesis blocker was 
employed. 
 HGF and V79-4 cell types were seeded in 3.5 cm of diameter tissue culture 
plates (Orange Scientifique) at least two passages after the cultures were unfroze and 
during the exponential growth phase. HGF cells were cultured in 2 ml of complete α-
MEM with a cell suspension of 1x105 cells/ml (experiment A) and 5x104 cells/ml 
(experiment B), while V79-4 were cultured at a concentration of 5x104 cells/ml 
(experiment A) and 2.5x104 cells/ml (experiment B). For experiment A, HGF were 
incubated for approximately 24 hours and V79-4 for about 12 hours, while for 
experiment B cells were incubated for an extra 24 hours. 
 Just before genotoxicity testing started, the toxic agents were diluted in fresh 
complete cell medium, according to the conditions listed in Table 10. The initial culture 
medium was aspirated from the wells and replaced by 1 ml of treatment medium. HGF 
and V79-4 cells were incubated for 1.5-2 normal cell cycles with the toxic agents.  
 After the toxicity testing, the culture medium was removed and the toxic waste 
was stored separately. Each culture plate was washed twice carefully with 1 ml of 
phosphate buffered saline (PBS, Sigma) in order not to remove the cells, followed by 
fixation with 1 ml of formaldehyde 3.7% for 30 minutes. Then, the cell membranes were 
permeabilized for 10 minutes with 1 ml of 0,5% tritonX100 (Sigma), to allow the action 
of 0.7 ml of RNase 100 µg/ml (Sigma) in PBS for 30 minutes. The nucleic material was 
stained with 0.7 ml of PI 10 µg/ml (Sigma) in PBS for 20 minutes. The excesses of 
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staining were washed 3 times with 1 ml of PBS and the plates were left to dry in the 
dark at room temperature. 
The plastic walls of the dried plates were cut and a cover slip was mounted with 
a small drop of a mounting medium (Eukitt® O. Kindler GmbH, Sigma-Aldrich, St. 
Louis, EE. UU.). After drying, the margins of the cover slip were isolated using a 
transparent varnish, left to dry in the dark at room temperature and stored at 4ºC. 
 
Table 10. Experimental conditions of the genotoxicity tests (MNvit) 
Experiment Cells Toxic agent Manufacturer Concentration 
A 
B 
HGF 
V79-4 
Control (-) _ 0 
EMS (µg/ml) 
Sigma-Aldrich 
600 
MMA (mM) 0.0037* 40 
Formaldehyde (µM) 100 
EMS – Ethyl methanesulfonate; MMA – Methyl methacrylate ; * Approximate value of the measured MMA 
at 72 hours (section D.1.) – 3.10x10
-4
 mg/ml ≈ 0.0037 mM 
 
 The plates were observed with a confocal multichannel microscope (Leica TCS 
SP2 AOBS, Leica Microsystems GmbH, Wetzlar, Germany) (Institute for Molecular and 
Cell Biology of the University of Porto) with fluorescence at 561 nm and a magnification 
of 400x. The number of micronuclei was counted in a minimum of 2000 cells per plate 
and recorded.107 Simultaneously, clastogenic and aneugenic micronuclei were 
distinguished and counted, according to the size-classified micronucleus method 
proposed by Hashimoto et al. (2010).122  
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C.7. Statistical Analysis 
 
 The results from the HPLC quantification of residual monomer were analyzed 
using Excel®. Whenever necessary, the Dixon test was applied for the analysis of 
outliers. MDL was calculated as 3•(standard error of the calibration) = 3•(sy/x) and MQL 
was determined as 10•(standard error of the calibration) = 10•(sy/x).  
The cytotoxicity and genotoxicity data were analyzed using Excel® and SPSS® 
V.18. The percent of cell viability was calculated for each well (n = 18) in relation to the 
mean absorbance of control wells. A descriptive analysis of the sample was performed 
and boxplots were analyzed for the existence of outliers. Additionally, agreement in 
controls’ viabilities between different experiments was calculated with the Cronbach’s 
Alpha. The normal distribution of the sample was confirmed by the Kolmogorov-
Smirnov test (p>0,05).  
 Two-way ANOVA test was performed to assess if there were differences 
between the % of viabilities of the three cell types with increasing doses of each 
separate chemical substance. Dunnett post-hoc tests were performed considering as 
control groups 0 for the chemicals concentrations and the V79-4 for cells. Though the 
general significance level was p<0.01, a Bonferroni correction was applied, resulting in 
a p<0.05 significance level, since 5 comparisons were performed. 
In relation to the genotoxicity tests, the percent of mononuclear cells with MN 
was calculated for the two experiments, as well as the proportion of clastogenic and 
aneugenic MN in 2000 cells each. The means of results from the two experiments 
performed were determined for the % of total cells with MN, cells with clastogenic MN 
and cells with aneugenic MN in 2000 cells. The cases (each experiment) were 
weighted for a frequency of 2000 cells (n = 2000), therefore the sample was assumed 
to follow a normal distribution. 
Independent-samples t-test was performed to assess if there were differences 
between the 2 cell types in terms of their total scores of cells with MN (p<0.05). 
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Moreover, one-way ANOVA test was applied to assess if there were differences in the 
total number of micronuclei for the 2 cell types and different chemicals. Each chemical 
was considered with the respective concentration as independent groups and no 
comparisons between concentrations were performed. The Dunnett post-hoc test was 
executed to compare each test chemical group with the negative control group in terms 
of % of cells with MN with the negative control group. Though the general significance 
level was p<0.01, a Bonferroni correction was applied, resulting in a p<0.05 
significance level, since 4 comparisons were performed. 
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D. RESULTS 
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D.1. Quantification of the Leachable Residual Monomer 
 
A typical calibration curve obtained with the described analytical procedure is 
plotted in Figure 7. MQL was set at 1.17x10-4 mg/ml. Since that the calculated MDL 
presented a statistical error <10%, it was considered to be equal to the MQL. In the 
MMA concentration range between 9.30x10-4 and 1.86 x10-2 mg/ml, good linear 
relationships were obtained. Figure 8 shows a typical MMA chromatogram, with a clean 
separated MMA peak detected around 5.20 minutes.  
 
 
Fig. 7 – MMA calibration curve in artificial saliva for HPLC with 95% of confidence levels. The slope of the 
line has a SD value of ±0.07. The y-axis intercept has a SD of ±16000 
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Fig. 8 – Typical MMA chromatogram (MMA concentration = 7.44x10
-4
 mg/ml) 
 
Despite the monomer pre-concentration prior to the HPLC quantification, the 
leached residual monomer into artificial saliva is very low (Table 11). After 24 hours of 
sample submersion, the MMA concentration is below the MQL/MDL, thus it is not 
possible to determine it with precision. However, the 72 hour test group obtained a low, 
but quantifiable concentration of leached residual monomer. According to the Dixon 
test, no outliers were found, so all results from the 6 samples of each group were 
considered. 
 
Table 11. Mean values of leached MMA into artificial saliva at 24 and 72 hours (n = 6, 
independent samples) 
Time (hours) 24 72 
Concentration (mg/ml) < 1.17x10-4 (MQL) 
3.10x10-4 
(Standard relative error:10%) 
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D.2. Cytotoxicity Testing 
 
Figure 9 illustrates the typical appearance of human fibroblasts at different 
steps of the cytotoxicity assay. Metabolically active fibroblast mitochondrias are 
capable of reducing the MTT into an insoluble formazan precipitate. Figure 10 shows a 
test 96-well plate prepared to be introduced in the microplate reader. It is observable 
that the fibroblasts viability decreases as the chemical concentration increases, since 
the color intensity of the solutions declines. 
 
 
Fig. 9 – Human fibroblasts’ morphology at different steps of the cytotoxicity testing (merely illustrative): a) 
cells during their exponential growth phase in normal culture conditions; b) negative control group of cells, 
showing extensive formazan precipitates upon MTT testing; c) test group of fibroblasts treated with 
cytotoxic concentrations of a chemical, presenting only a few small formazan precipitates upon incubation 
with MTT (a), b), c) 330x magnification, inverted microscope, no staining) 
 
 
Fig. 10 – Illustrative 96-well plates MTT test for HGF cells (n = 6 for each test group in each microplate). 
The experiences were triplicated (final n = 18). Rows: a) negative control; b) EMS 600 µg/ml; c) EMS 1200 
µg/ml; d) EMS 2400 µg/ml; e) MMA 40 mM; f) MMA 80 mM; g) MMA 160 mM; h) negative control; i) 
negative control; j) formaldehyde 400 µM; l) formaldehyde 800 µM; m) formaldehyde 1600 µM  
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The means and SDs for each test group are presented in Table 12. 
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The complete statistical analysis for this section is presented in the Annex 
section (H 1. Cytotoxicity Test Statistical Analysis Output). Firstly, the descriptive 
statistic analysis was made for each chemical. It showed that in the case of EMS (ethyl 
methanesulfonate) there was an outlier group of 6 wells (HGF at 600 µg/ml), which was 
considered missing, though it does not seem to affect much the outcome. Boxplot 
graphics (Figure 11) are presented to evaluate the outlier cases behavior. However, 
since there are n = 18 cases per toxic agent/concentration/cell type, the outliers 
highlighted in the boxplots were not excluded, since they do not affect the outcomes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 11 – Boxplots per toxic agents with outliers: a) EMS; b) MMA; c) Formaldehyde.  
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The Cronbach’s Alpha test showed that there was concordance between the 
three independent experiments (84.4%).  
The two-way ANOVA test presented a high observed power (approximately 
1.000). The cells’ viability curves with the doubling toxic concentrations are plotted 
separately for each chemical agent (Figure 12 to 14), with 99% confidence intervals. 
It was verified that for every chemical agents, there was a significant decrease 
(p<0.01) between the viabilities of the control groups and the other concentrations for 
all cell lines. On the other hand, despite an overall tendency of HGF and WI-38 to show 
higher viability values than V79-4, the effects on the three cell types are not statistically 
significant (p>0.01). 
In general, the cells’ viability seems to decrease almost linearly with doubling 
doses of EMS (Figure 12). MMA causes an initial progressive decrease in the cells’ 
viability, but somewhere between 80 and 160 mM, the cells survival falls remarkably 
(Figure 13). Conversely, formaldehyde causes a marked decrease on viability right at 
the lowest concentration tested and then the toxic effect seems to be progress slower 
(Figure 14). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 12 – Separate cells viability curve for EMS with 99% of confidence levels 
 
67 
 
Fig. 13 – Separate cells viability curve for MMA with 99% of confidence levels 
 
 
Fig. 14 – Separate cells viability curve for formaldehyde with 99% of confidence levels 
 
  
 
68 
D.3. Genotoxicity Testing 
 
 Figures 15 to 34 show examples of cell nuclei observed during the MN scoring 
at the confocal fluorescent microscope (PI staining). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 17 – HGF cell with two clastogenic MN (arrows) inside the cytoplasm 
 
 
 
 
Fig. 15 – HGF cell with a clastogenic MN (arrow) Fig. 16 – HGF cell with a borderline calstogenic MN 
(arrow) 
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Fig. 18 – HGF cell with an aneugenic MN (arrow) Fig. 19 – HGF cell with a very small borderline MN 
(white arrow) and a large clastogenic MN (yellow 
arrow), which was not considered aneugenic 
Fig. 22 – Two recently formed HGF cells, united by 
a NPB (yellow arrow), one of them has a large 
NBUD (green arrow) and the other has a 
clastogenic MN (white arrow) 
Fig. 20 – HGF cell with three clastogenic MN 
(arrows) 
Fig. 21 – HGF cell with a NBUD (arrow) that could be 
easily confounded with a clastogenic MN 
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Fig. 23 – V79-4 cell with a clastogenic MN (arrow) Fig. 24 – V79-4 cell with an aneugenic MN (arrow) 
Fig. 25 – Two V79-4 cells each with its own MN 
(arrows) 
Fig. 26 – A magnification of the previous figure 
shows that when the MN are measured one of them 
is aneugenic (white arrow in Figure 25) and the 
other is clastogenic (yellow arrow in Figure 25) 
Fig. 27 – A defective mitosis (cytokinesis) resulted in 
the formation of two MN (arrow), one for each V79-4 
daughter cell 
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Fig. 28 – One of the V79-4 cells has a clastogenic MN (yellow arrow), while another has a small NBUD 
(white arrow) 
 
 
Fig. 29 – One of the V79-4 cells has an aneugenic MN (yellow arrow), while another has a small NBUD 
(white arrow) 
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Fig. 30 – V79-4 cell with a large borderline 
aneugenic MN (arrow) 
Fig. 31 – A defective mitosis (anaphase) of a V79-4 
cell is resulting in the formation of an aneugenic MN 
(arrow), possibly a lagging chromosome 
Fig. 32 – V79-4 cells united by a NPB (arrow) Fig. 33 – A group of V79-4 cells (possibly 
descendent from the same mother cell) where most 
of the cells  have their own MN 
Fig. 34 – Overview of the great density of V79-4 
cells 
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 The detailed statistical analysis in presented in the Annex section (H 2. 
Genotoxicity Test Statistical Analysis Output). Table 13 presents the % of total cells 
with one or more MN in 2000 mononuclear cells.  
 
Table 13. Cells with MN in 2000 mononuclear cells (%) (mean of experiments A and B) 
Cells Toxic agent/Concentration 
Total cells 
with MN 
Cells with 
Clastogenic 
MN 
Cells with 
Aneugenic 
MN 
H
G
F
 
Control (-): 0 7,19% 6,89% 0,30% 
EMS: 600 µg/ml 9,72%* 9,34% 0,37% 
MMA: 0.0037mM 5,16% 4,64% 0,52% 
MMA: 40mM 6,16% 5,97% 0,20% 
Formaldehyde 100 µM 7,10% 6,97% 0,12% 
V
7
9
-4
 
Control (-): 0 0,99% 0,82% 0,17% 
EMS: 600 µg/ml 4,57%* 4,02% 0,54% 
MMA: 0.0037mM 0,88% 0,73% 0,15% 
MMA: 40mM 1,00% 0,95% 0,05% 
Formaldehyde 100 µM 0,65% 0,62% 0,02% 
* statistically significant differences (p<0.001) in the % of total cells with MN between test groups and the 
respective negative control (One-way ANOVA analysis) 
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The sample was analyzed for outlier cases (Figure 35), though none were 
excluded, since the n was high (n = 2000) and the outcome was not affected. 
 
 
Fig. 35 – Boxplots with outliers: a) Toxic Agent (Labels: 0 – Control (-); 1 – EMS 600 µg/ml; 2 – MMA 
0.0037 mM; 3 – MMA 40 mM; 4 – Formaldehyde 100 µM); b) Cells. (Labels: 1 – HGF; 2 – V79-4) 
 
Though the equality of variances could not be assumed, independent-samples 
t-test showed that there is a statistically significant difference (p<0.05) in the % of total 
cells with MN between the two cell types: HGF presents constantly higher scores of 
MN than V79-4 (MN baseline 7.19% vs. 0.99%).  
Although no homogeneity of variances was verified for this sample for one-way 
ANOVA analysis, the Brown-Forsythe robust test of equality of means was statistically 
significant (p<0.001). The Dunnett post-hoc test showed that for both cell types there 
are significantly higher scores of cells with MN in the EMS group (positive control) than 
the MN baseline (negative control) (p<0.001). This increasing is more notorious for the 
V79-4 cell type (approximately 4.6-fold) than for HGF (approximately 1.4-fold). 
However, no differences to the control group are verified for formaldehyde and MMA at 
the tested concentrations (p>0.01). 
 Figures 36 and 37 represent the ratio of cells with clastogenic and aneugenic 
MN for HGF and V79-4 cells, respectively, measured for the first time, with the 
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indicated toxic using the size method proposed by Hashimoto et al. (2010).122 In both 
cases there is a clear predominance of clastogenic MN independently of test groups. 
 
 
Fig. 36 – Ratio of clastogenic/aneugenic MN in 2000 cells scored for HGF cells (cell test group).  
 
 
Fig. 37 – Ratio of clastogenic/aneugenic MN in 2000 cells scored for V79-4 cells (cell control group)  
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E. DISCUSSION 
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E.1. Leached Residual Monomer 
 
As referred before, one of the main aims of the present research was to verify 
whether the residual monomer released in simulated oral conditions by a commercial 
heat polymerizable denture base polymer had genotoxic effects on oral fibroblasts. The 
first results obtained show that the resin studied leaches a very low quantity of MMA 
residual monomer (near the LOQ) into the artificial saliva formula used at 37ºC. As it 
will be further discussed bellow, the monomer extraction conditions followed the ISO 
standards and the quantification method has a very low MLD. It may be hypothesized 
that these results are due to the features of the material tested. 
The acrylic resin chosen (ProBase Hot, Ivoclar) is one of the most widely used 
denture base polymers in the market. It is a denture base Type 1 powder-liquid (Class 
1) material 5 composed essentially by the MMA monomer, though it also has a small 
proportion of EGDMA as a cross-linking agent (manufacturer instructions of use). The 
manufacturer of the acrylic resin chosen declares that the content of residual monomer 
of this material is lower than 2.2% (w/w) after following the standard polymerization 
protocol (manufacturer instructions of use), therefore complying with the ISO 20795-
1:2008 recommendation. As stated previously, cross linked polymers have better 
physical and mechanical properties and are more difficult to expand and release 
molecules,12,126 thus being the most plausible explanation for the low MMA 
concentration obtained in this study. Vallittu et al. (1998) determined the total content of 
residual monomer according to the ISO standard for precisely this brand of heat 
polymerizable material.126 Interestingly, they found that when compared with other 
conventional brands of acrylic resins (Lucitone 199) cured in the same conditions, the 
total content of residual monomer was inferior for ProBase Hot.126 Therefore, it would 
be expectable that the mount of leached monomer would also be low, which would be 
in agreement with our results in the leaching assay using this acrylic resin. 
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Urban et al. (2012, 2009) have been comparing the leaching properties of 
autopolymerizable hard relining denture polymers with and without cross linking 
features into artificial saliva. They came to the conclusion that materials with 
bifunctional monomers (such as 1,6-HDMA) promote the formation of a cross linked 
network and a higher degree of conversion, thus releasing less amounts of monomer 36 
and byproducts.127 Still, the concentration of leached monomer in artificial saliva from 
the cross linked materials is in the range of 1-6 µg/ml (ppm range).36 These 
concentrations are higher than those obtained in the present research, probably due to 
the fact that autopolimerazable materials usually present a worst degree of conversion 
compared to heat polymerizable polymers. Moreover, Çelebi et al. (2008) refer to a 
study by Koda et al. (1990) in which it was not possible to determine the amount of 
leached monomer from heat and microwave cured resins into artificial saliva, since that 
the concentrations were below a reliable determination range.128 
In terms of the test conditions, the protocol employed followed the 
recommendations in ISO 10993-12:2007, which provides a standardized approach that 
is an appropriate exaggeration of product use.80 However, it was noticed that when 
assessing the state of the art in this field, there is no consensus between the different 
authors in terms of the followed methodologies. Hence, it becomes very difficult to 
compare the present results with theirs and to draw definite conclusions.  
In the present research, an extraction ratio of 3 cm2/ml was employed, 
respecting the guideline for larger moulded items (thickness > 1.0 mm), and the solvent 
volume used was a function of the surface area of the polymer discs.80 Although 
suggested by the ISO 10993-12:2007 norm, the samples were not cut in pieces for this 
assay, because prosthetic devices are used by the patients as a single piece and there 
may be potential differences in extraction characteristics between intact and cut 
surfaces.80 The extraction ratio is one of the most important variables in this type of 
study, since it influences directly the concentration of monomer quantified. 
Consequently, the effects of a given material may be under or over-estimated and, as a 
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result, misevaluated. Most published articles 19,27,32,36,41,43-45,48,52,102,127-132 present 
extraction ratios under 3 cm2/ml, except for Danesh et al. (2011), whose extraction ratio 
is approximately 5 cm2/ml.30 As a consequence, in this particular case, there may be a 
higher concentration of leachable residual monomer in the solvent and, eventually, a 
worse toxic effect. Bural et al. (2011a,b) refers to a withdrawn ISO standard (ISO 
10993-5:1999) 133 for cytotoxicity testing to justify the extraction ratio used (0,626 
cm2/mL).32,102 However, this latter guideline refers to ISO 10993 Part 12 when it comes 
to prepare liquid extracts of a material. 
Also, according to the ISO standard, the extraction period chosen for an assay 
is dependent on the temperature appropriated for the simulated test situation. In the 
case of the present work, 37ºC was the most appropriated temperature to simulate the 
oral conditions, thus an extraction period of 72 hours was recommended by the 
standard. Since it has been claimed by several authors that most of the leachable 
residual monomer is released in the first few hours of contact with the 
solvent,27,30,36,41,128,129,132,134 samples were also evaluated at 24 hours.  
Another source of variability comes from the fact that only a minority of authors 
performed the quantification of the extracts in independent samples 30 and most of the 
studies use the same sample for the subsequent measures. Moreover, in the latter 
cases, the solvent was sometimes maintained throughout the whole 
experience.19,129,130,132 In other experiments the whole volume was substituted by fresh 
solvent after each test period,27,32,41,43,102,128 or every 24 hours.36,127,129,131 
 On the other hand, the extraction conditions section in the ISO guideline 
recommended that an extraction period of 24 hours at 37ºC was only acceptable in 
case that the solvent chosen was tissue culture media for cytotoxicity testing. In the 
current investigation no extraction was performed with complete α-MEM. The 
quantification method was developed for inorganic artificial saliva, which composition is 
less complex than that of complete α-MEM. Further studies are needed to build a 
calibration curve for MMA in an organic matrix as complex as complete α-MEM, so as 
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to allow the quantification of leachable MMA. Culture medium with serum is 
appropriated for cell growth, as well as to extract both polar and non polar molecules.83 
However, this approach has not been explored very often. Bural et al. (2011a, 2011b) 
extracted the residual monomer for 24 hours at 37ºC using tissue culture medium but 
without serum, therefore not totally complying with the ISO 10993 Parts 5 and 12 
recommendations.32,80,83,102 According to the ISO recommendations, culture medium 
without serum is only specifically appropriated for polar substances such as ions.83  
They reported to add the serum just before cytotoxicity testing,32,102 which probably 
caused a dilution of the leached residual monomer. 
Though acceptable according to the ISO 10993-12:2007, another feature that 
contributes to the published methodologies’ heterogeneity is the high variability of 
solvents used, particularly artificial saliva, whose composition diverged between 
studies from different authors 30,36,127,129 (see Annex H.3. Table1). Because of this 
notorious lack of agreement, a standardized formula was chosen for this research. On 
the contrary to Urban et al. (2012, 2009) 36,127 and in natural saliva, it must be noticed 
that this formula is totally inorganic and polar, which may have affected the capacity of 
this vehicle to penetrate the polymer matrix and dissolve the residual MMA.132 Hence, it 
may be partially responsible for the low concentration of MMA in the samples, having in 
mind that in clinical conditions the amount of monomer leached may be higher.  
Moreover, some studies use an ethanol solution (variable or unknown % v/v) as 
a solvent,19,130,132 which used to be recommended by the U S Food and Drug 
Administration (FDA) as an oral environment simulator (at 75% v/v).15,16,54,135 Yet it has 
been claimed by some authors that it promotes an excessive diffusion of monomers by 
expanding the polymer network.17,30 
In order to quantify the released MMA monomer into artificial saliva, the 
chromatographic methods proposed by ISO 20795 were considered as the most 
indicated techniques to perform the exact quantification of the leachable residual 
monomer. In the published monomer leaching studies, though most authors agree in 
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using chromatography,19,27,30,32,36,41,48,102,127-130,132 a minority preferred to quantify 
through UV spectrophotometry.43-45,52,131 Despite this latter technique is valid for 
quantification in many situations, chromatography is more accurate and sensitive 
because there is a chemical separation and concentration of closely related but distinct 
monomer molecules, which may be present in the solution, before the quantification 
itself.58 Furthermore, before MMA quantification, a microextraction pre-concentration 
technique was employed, which fairly improved the MDL and MQL. When compared to 
other studies,30,128 the MDL and MQL of the present research is more favorable to 
detect minimal monomer concentrations. 
 
 
E.2. MMA Cytotoxicity 
 
Prosthodontic materials’ clinical success is dependent not only on their 
physical/mechanical and chemical properties, but also on their biologic effects and 
safety. Since that one of the goals of this research was to evaluate the potential 
genotoxic effect of leachable MMA from a conventional prosthetic polymer, it was first 
necessary to assess the cytotoxic profile of MMA. As most in vitro models used to 
evaluate toxicity of dental base polymers rely on non-human immortalized cell lines 
from different (non-oral) tissues, in this study an untransformed HGF cell line was 
evaluated as a research oral cell model. For both purposes, control chemicals (EMS 
and formaldehyde) and control cell types (V79-4 and WI-38) were also tested. 
EMS is an alkylatying agent (clastogen) 123 that has been very often used as a 
positive control in genotoxicity assays.24,95-97,136,137 To our knowledge, this is the first 
report where EMS is tested in a commercial untransformed HGF cell line. In the 
present investigation there was a clear dose-dependent effect for all cell types tested. 
As the EMS doses doubled, the cells viability progressively diminished. On the other 
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hand, MMA and formaldehyde do not present such a predictable effect on cells. 
Although for lower MMA concentrations the cells viability decreased gradually, in the 
last doubling dose the viability sharply declined. Probably, when a certain degree of cell 
impairment is reached it causes irreversible and catastrophic damage leading to the 
death of most cells. In the case of formaldehyde, the results corroborate that it is a 
powerful cytotoxic agent at relatively low doses. It would have been interesting to 
evaluate the progression of cell viability for formaldehyde doses lower than 400 µM, 
though it is still predictable that the viability would diminish in an exponential fashion. 
 In terms of the influence of the cell types on the viability variation, no differences 
were found, i.e. for all chemicals the cells’ viability response was the same. However, 
the data suggests that the human untransformed fibroblasts tend to be more resistant 
to MMA and formaldehyde than V79-4 cells, which may be nearer to a physiological 
response. It must be considered that V79-4 and WI-38 are widely used and 
recommended as in vitro test models for cytotoxicity 83 (and V79-4 for genotoxicity 
testing as well 107). Therefore, if the HGF cell line presents a similar viability behavior, it 
may also be considered a reliable cell model. HGF has the advantages of being an 
untransformed human cell line, just like WI-38, and it came from an oral tissue, which, 
at least theoretically, should be closer to the oral physiological conditions than one of 
the most employed cell lines V79-4 (immortalized, non-human and non-oral). 
 As referred previously, most studies concerning the cytotoxicity of MMA 
employed either immortalized cell lines or primary cells and a wide variety of 
cytotoxicity tests have been applied. In the present study, the 50% cell viability was 
reached with a concentration between 80 and 160 mM. Lai et al. (2004) had similar 
results to those of the present study. For a 50% primary HGF and PDL viability 
(determined by the MTT assay), they had a MMA concentration of 1.2%,14 
corresponding approximately to 120 mM. The same authors also tested 1,6-HDMA and 
isobutyl methacrylate (IBMA) and stated that since most monomers are released in the 
first hour after polymerization, the direct application of uncured relining materials in the 
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oral cavity may seriously irritate the mucosa and cause cell death by either necrosis or 
apoptosis.14 
 Conversely, some authors found that lower concentrations of MMA were 
necessary to reach 50% cell viability.24,35,68,79,101 It might be explained by possible 
differences in the type of cytotoxicity assays employed, different cell types and growth 
rates at the moment of the test that may influence the outcomes.  
 In a systematic review by Chaves et al. (2012), the cytotoxicty of denture base 
and hard chairside resins was evaluated. They found some evidence that heat-
polymerizable resins (thermo and microwave) are less cytotoxic than 
autopolymerizable and light or dual-cured materials.18 However, the conclusions were 
not definitive, since there are too many variables and heterogeneity in the studies 
analyzed, in terms of the cell types, cytotoxicity tests employed, brands and 
polymerization cycles of the resins evaluated.18 Bural et al. (2011a, 2011b) studied the 
effects of different polymerization cycles and post polymerization treatments in the 
elution and cytotoxicity on L929 cells of autopolymerizable and heat-polymerizable 
resins, respectively.32,102 In the autopolymerizable materials study, a higher degree of 
conversion and a lower leached MMA did not always mean that the cytotoxicity would 
be lower.102 Conversely, a reduction in the leached MMA increased the L929 viability 
for heat-polymerizable resins.32 In general it was considered that the materials were 
slightly cytotoxic.32,102 
 However, it seems that the cells viability is not only dependent on the quantity of 
residual monomer released. In a study by Rose et al. (2000) found that despite light-
cured orthodontic resins released less UDMA than the autopolymerizable leached 
MMA, the MTT test on L929 cells showed a lower viability caused by UDMA.27 
Therefore, UDMA is more cytotoxic than MMA even at lower concentrations.27 Atsumi 
et al. (2006) showed that when compared with other hydrophobic monomers like BA (n-
butyl acrylate), BMA (n-butyl methacrylate), IBMA, HMA (n-hexyl methacrylate) and 
DMA (n-dodecyl methacrylate), MMA was the less cytotoxic.35 These results were 
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comparable to those found for hydrophilic dental molecules in the same study, which 
are not as cytotoxic since that they have more difficulty to cross the lipid bilayer cell 
membrane to penetrate the cells.35 Furthermore, Lai et al. (2004) explain that the 
monomers 1,6-HDMA are more lipophilic and more cytotoxic than IBMA, which in turn 
is more hydrophobic and toxic than MMA.14 Schweikl et al. (2001) found that MMA and 
HEMA, which are monofunctional monomers, were less toxic than the composite 
resins’ bifunctional monomers like TEGDMA, UDMA and bis-GMA.24 
 Similarly to Yang et al. (2003),68 the results obtained by Jorge et al. (2004) 
show how different cytotoxity tests employed may have totally different outcomes.84 
They found that independent on the materials used and test groups, the resins had a 
cytotoxic effect when evaluated through the 3H-thymidine assay, but were not cytotoxic 
when the MTT test was applied.84 
To our knowledge, cytotoxic testing using untransformed HGF cell line is very 
limited and there are very few reports regarding dental polymers. Reichl et al. (2006) 
used a HGF untransformed cell line to evaluate the response to amalgam and to co-
monomers from restorative dental composites.138 A dose-dependent loss of cell viability 
was observed and the XTT assay also showed that HEMA was the less cytotoxic 
substance, followed by TEGDMA, UDMA, bis-GMA and the mercury molecules.138 In 
another study, Reichl et al. (2010) found that the same HGF cell line expresses an 
enzyme from the cytochrome P450 superfamily and is capable of metabolizing 
methacrylic acid (MA), which is a toxic subproduct of the metabolization of methacrylic 
co-monomers.139 It may be hypothesized that the HGF cell line tested in the present 
research also expresses an enzyme from the cytochrome P450 superfamily and may 
be capable of metabolizing methacrylic subproducts. This may explain why these cells 
seem to be more resistant to MMA aggressions than the immortalized cell lines 
previously referred. 
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Furthermore, the viability of the present HGF cell line had already been 
evaluated for nicotine 115 and for single-wall carbon nanotubes.118 In both cases it was 
found that its response depended on the doses employed.  
 
 
E.3. MMA Genotoxicity 
 
 The final purpose of this research was to evaluate whether MMA was a 
genotoxic molecule. This issue has been gaining relevance because viable cells with 
serious DNA lesions are likely to initiate a carcinogenesis process.68 Besides, the HGF 
profile as an oral cell model for the MNvit test was evaluated because, according to 
Parry et al. (2010), it is important to use cells as similar as possible to the in vivo tissue 
that contacts more directly with the chemical that is being studied.114 The cells should 
be as closer to the human in vivo cells as possible and should at least be capable of 
expressing the p53 gene or other genes essential for normal genotoxic responses.114 
The MMA concentration (0.0037mM) close to the value determined by HPLC for 
the 72 hours group was chosen for the genotoxicity test. Moreover, based on the 
results obtained in the MTT assay, non-cytotoxic MMA, EMS and formaldehyde 
concentrations were compared in terms of the MN frequencies in 2000 cells. In the 
genotoxicity section, the MNvit assay was performed with the HGF cell line and with 
only one control, the immortalized V79-4 cell line, which was the most referenced and 
recommended by the international guidelines.107  
 Minimal criteria proposed by Parry et al (2010) were accomplished in this MNvit 
assay: duplicate cultures were performed; positive (EMS 600 µg/ml) and negative 
controls were used; good quality of the cells preparation, with visible cell membrane at 
the microscope; validated guidelines for MN scoring were followed 106 and an adequate 
cell number was counted.114 
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 Interestingly, the amount of MN/2000 cells in the negative control of HGF was 
significantly higher than the baseline MN score in V79-4. In fact, OECD suggested that 
in negative control groups for the recommended cell types, such as V79-4, the count 
should be 5-25/1000 cells with MN,107 which corresponds approximately to 0.5-2.5% 
MN score. The result of the V79-4 negative control group (0.99%) fits perfectly this 
interval, thus validating the procedures performed. In the HGF negative control group 
the MN score was quite higher (7.19%). 
Since that at 600 µg/ml EMS did not register a significant difference in the cells’ 
viability from the negative controls, it was selected as the positive control drug for the 
MNvit assay. The present results confirm that EMS works well as a positive control in 
both cell types, given that the MN count increased significantly when compared with 
the negative control. However, in relation to the HGF cells, the increasing in the total 
score of MN was not as marked as in V79-4 cells. 
 In the V79-4 group no differences were found for none of the MMA 
concentrations and formaldehyde in relation to the control group. Therefore it may be 
assumed that these chemicals at the tested concentrations are not genotoxic for these 
cells. Despite that in the lowest MMA concentration tested in the HGF group the MN 
scores are bellow the scores in the negative control, this difference is not meaningful. 
 EMS has been previously classified as a clastogen agent by the FISH 
method.123 However, the present study employed the size-classification method of MN 
proposed by Hashimoto et al. (2010).122 For the first time, EMS was confirmed to be a 
clastogen with the latter method. Thus, the present report corroborates the usefulness 
of the size-classification method. 
 To our knowledge, only a research group has been testing this particular HGF 
cell line for MNvit testing, though the substances tested are not related to dental resin 
acrylics.115,116,118 In general, it was noticed that the percents of MN in the present study 
(5.16 to 9.72%) are slightly higher than in all nicotine groups (>1.5 to <6%) tested by 
Argentin et al. (2004, 2006).115,116 In the case of the study with single-wall carbon 
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nanotubes all the MN scores (>0.05 to <3.5%) were equally lower than in the present 
study.118 One of the factors that might explain these differences is that the materials 
tested are different; even between the referred studies, which followed the same MNvit 
protocol, the MN scores varied in slightly different ranges. Another relevant fact is that 
the protocol followed by Argentin and Chichetti et al. was different from the present 
procedures since they followed the CBMN protocol and counted only 1000 binucleated 
cells.115,116,118 Though both procedures are considered valid by the OECD 487 guideline 
in terms of the relative MN scores (negative controls vs. test group), there may be 
differences in the absolute number of MN counted between assays with and without 
cytokinesis blocker. More importantly, it has been reported that the Giemsa stain 
employed by the former authors is not the most reliable, as it may not detect all MN 
present in the cells.121 Conversely, in the present research the DNA was specifically 
stained with PI and was observed at the confocal fluorescence microscope. This 
observation technique is more specific and sensitive.121 thus probably more MN were 
distinguished and scored. Finally, despite the MN morphologic features are well 
described and scoring guidelines are well established, there might be slight differences 
in the scoring criteria too. 
 Since the 90’s that an increasing concern on the genotoxicity of dental medical 
products has lead to the publication of several studies. Root canal sealers, dentin 
bondings, composite resins and their components have been target materials. Denture 
and orthodontic base polymers have not been as studied. Yang et al. (2003) tested the 
genetoxic profile of MMA on CHO cells through the CA and SCE assays, which 
detected structural defects in chromosomes, just like MN.68 On the contrary to the 
results of the present study, they registered a dose-dependent increase in the number 
of CAs (chromatid-type aberrations – gaps and breaks) and SCEs (intra and interstrand 
cross-links), suggesting MMA as a potential clastogen.68 Schweikl et al. (2001) cited 
that an approximate 100% correlation had been established between the CA assay and 
the MNvit test.24 However, the CA assay is not considered as predictive of in vivo 
 
88 
genotoxic or carcinogenic activity as the MNvit assay,114 so the clinical relevance of 
these results might be minimal. 
 Composite resin monomers have also been studied for their genotoxicty. 
Schweikl et al. (2001) reported a dose-related increase in the numbers of MN for 
unpolymerized TEGDMA, HEMA and glycidyl methacrylate (GMA) under physiological 
conditions; also high concentrations of MMA and bisphenol A induced elevated 
numbers of MN associated with cytotoxicity, and a very low mutagenic activity for Bis-
GMA and UDMA.24 
Dorn et al. (2008) extended the investigations on the non-specific mechanisms 
that explain the dental monomers’ genotoxic profile. The monomers’ lipophilicity has a 
great impact on disturbing the hydrophilic processes that occur during the cell cycle. It 
interferes with karyokinesis by disturbing DNA synthesis, which may be sensitive for 
hydrophobic interactions; it may induce lysosomal breakdown and subsequent DNase 
release from lysosomes, thus causing DNA double strand breaks and chromosomal 
aberrations, leading to clastogenicity. Moreover it perturbs cytokinesis, leading to 
rearrangement processes of actin and astral and interzonal microtubules and 
consequent aneugenic defects.140  
In addition, authors have been deeply studying the possibility that apoptosis and 
mutagenicity induced by resin monomers could be mediated by oxidative stress. A 
2006 study on V79-4 fibroblasts and RPC-C2A pulp cells revealed that GMA, TEGDMA 
and HEMA induced cytotoxicity, apoptosis and genotoxicity was dose-dependent, but 
both were significantly decreased by co-treatment with N-acetylcystein (NAC), an 
antioxidant.141 Further studies, where the MNvit test was also applied, found similar 
results for TEGDMA, HEMA 142 and bonding agents of dental adhesives in V79 cells,137 
as well as for camphorquinone in CHO cells in co-treatment with the reducing agent 
N,N-dimethyl-p-toluidine.109 Recent investigations with resinous canal sealers 
concluded that the formation of MN was induced by the generation of ROS,95 whereas 
pulp capping materials like castor oil bean cement and mineral trioxide aggregate 
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(MTA) were considered safe.96 In another research in this field in 2010, TEGDMA was 
confirmed to arrest cell cycle by the production of ROS, by comparison with adriamycin 
and mitomycin C, two chemotherapeutic agents, which arrest the cell cycle through 
different mechanisms.143 Therefore, when the production of ROS exceeds the cell 
redox balance capacity, strand DNA breaks may happen, activating the genetic repair 
mechanisms, programmed cell death or, at worst, the occurrence of 
mutagenesis.95,137,142,144  
 
 
E.4. Perspectives For Future Research  
 
 Biocompatibility and biological risk assessment of medical devices is a never 
ending science issue, since that more than ever it is an absolute requirement when 
providing the best human health care. The same principle applies in prosthodontics. 
 In terms of the present study, it would be important to further develop and 
validate the analytical procedures of quantification of residual monomer with the 
microextraction technique and HPLC, namely in more complex solvents such as 
complete α-MEM or even natural saliva. Moreover, it would be interesting to investigate 
the amount of other potentially toxic leachable molecules. Once these procedures are 
validated and systematized, it will be easier to apply them to a wider variety of 
commercially available polymeric materials or before being launched into the market. 
 Moreover, the present study design included tests on extracts, but ISO 10993-
5:2009 also recommends other types of methodological approaches such as direct and 
indirect contact between the test material and the cells.83 These experiments could 
provide further information about the interactions between the cells, the polymer piece 
and its leachable molecules. Besides, the results already obtained should be 
consolidated and expanded, in order to obtain a thoroughly characterization of the 
suitability of HGF as an oral cell model for in vitro genotoxicity testing. 
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Furthermore, when compared to in vitro experiments, in vivo studies in these 
fields are virtually inexistent.9 Therefore, the next step in terms of investigation should 
include clinical evaluations on the human exposure and the real biological risks of 
leachable molecules from dental devices. More specifically, studies are already being 
developed to evaluate the levels of MN in exfoliated cells caused by oral conditions 
such as periodontitis.94 It could be very useful to objectively measure the levels of 
leached molecules from polymer based devices and the scores of MN. 
 More studies are also needed to keep on developing the promising MNvit 
method. When it is fully characterized and validated, automatic systems could be 
developed for a simpler, faster and even more reliable and reproducible scoring of MN. 
Moreover, further studies should explore and validate the size-classification method of 
MN, as well as other practical techniques for distinguishing clastogenic and aneugenic 
MN. Since it is considered a “cytome” assay of chromosomal instability, mitotic 
dysfunction and cell death,145 in the near future MNvit will probably become very helpful 
in the assessment of cancer risk. 
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F. CONCLUSIONS 
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 The main purpose of the present study was to evaluate in vitro the potential 
genotoxic effects of acrylic resins on human gingival fibroblasts. It may be stated that 
all objectives proposed for this research were accomplished. The main conclusions that 
can be drawn are: 
1. The newly developed microextraction technique in association with an 
optimized HPLC methodology reduced the MQL and MDL of MMA in 
artificial saliva; 
2. MMA residual monomer in artificial saliva is only detectable after 72 hours of 
extraction and the concentration is around the MQL; 
3. MMA decreases the viability of the HGF , V79-4 and WI-38 cell types for 
concentrations between 40 and 160 mM; 
4. MMA did not induce genotoxic damage on the HGF or V79-4 cell lines for 
the concentrations assessed; 
5. A properly fabricated cross-linking heat-polymerized appliance does not 
represent a high toxic risk in terms of the leached MMA; 
6. The HGF cell line proved to be a suitable and useful tool as a model for in 
vitro cytotoxicity testing; 
7. Further investigations need to be planned using HGF cells for the MNvit 
assay. 
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H.1. Cytotoxicity Test Statistical Analysis Output 
 
 For further details on the statistical analysis, please consult the respective file 
on the annexed CD. 
 
Univariate Analysis of Variance EMS 
 
Tests of Between-Subjects Effects 
Dependent Variable: Cell viability (%) 
Source Type III Sum 
of Squares 
df Mean 
Square 
F Sig. Noncent. 
Parameter 
Observed 
Power
b
 
Corrected Model 98206,812
a
 11 8927,892 75,300 ,000 828,299 1,000 
Intercept 1341622,857 1 
1341622,85
7 
11315,56
0 
,000 11315,560 1,000 
Concentration 84864,435 3 28288,145 238,589 ,000 715,766 1,000 
Celltype 8453,138 2 4226,569 35,648 ,000 71,296 1,000 
Concentration * 
Celltype 
5088,777 6 848,129 7,153 ,000 42,920 ,997 
Error 23475,755 198 118,564     
Total 1465747,319 210      
Corrected Total 121682,567 209      
a. R Squared = ,807 (Adjusted R Squared = ,796) 
b. Computed using alpha = ,01 
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Post Hoc Tests 
 
Concentration 
Multiple Comparisons 
Dependent Variable: Cell viability (%)  
 Dunnett t (<control) 
(I) Concentration (J) Concentration Mean Difference 
(I-J) 
Std. Error Sig. 99% Confidence 
Interval 
Upper Bound 
600 0 -10,6763
*
 2,16003 ,000 -4,8161 
1200 0 -25,0116
*
 2,09554 ,000 -19,3263 
2400 0 -53,0029
*
 2,09554 ,000 -47,3176 
Based on observed means. 
 The error term is Mean Square(Error) = 118,564. 
*. The mean difference is significant at the ,01 level. 
a. Dunnett t-tests treat one group as a control, and compare all other groups against it. 
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Homogeneous Subsets 
 
Cell type 
Multiple Comparisons 
Dependent Variable: Cell viability (%)  
 Dunnett t (<control) 
(I) Cell type (J) Cell type Mean Difference 
(I-J) 
Std. Error Sig. 99% Confidence 
Interval 
Upper Bound 
HGF V-79 5,4767 1,85558 1,000 10,2690 
Wi-38 V-79 15,3011 1,81479 1,000 19,9880 
Based on observed means. 
 The error term is Mean Square(Error) = 118,564. 
a. Dunnett t-tests treat one group as a control, and compare all other groups against it. 
 
Profile Plots 
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Univariate Analysis of Variance MMA 
 
Tests of Between-Subjects Effects 
Dependent Variable: Cell viability (%) 
Source Type III Sum 
of Squares 
df Mean 
Square 
F Sig. Noncent. 
Parameter 
Observed 
Power
b
 
Corrected Model 109693,709
a
 11 9972,155 62,317 ,000 685,485 1,000 
Intercept 1315632,271 1 
1315632,27
1 
8221,49
4 
,000 8221,494 1,000 
Concentration 106077,307 3 35359,102 220,962 ,000 662,886 1,000 
Celltype 309,591 2 154,796 ,967 ,382 1,935 ,079 
Concentration * 
Celltype 
3306,811 6 551,135 3,444 ,003 20,665 ,827 
Error 32644,795 204 160,024     
Total 1457970,775 216      
Corrected Total 142338,504 215      
a. R Squared = ,771 (Adjusted R Squared = ,758) 
b. Computed using alpha = ,01 
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Post Hoc Tests 
 
Concentration 
 
Multiple Comparisons 
Dependent Variable: Cell viability (%)  
 Dunnett t (<control) 
(I) Concentration (J) Concentration Mean Difference 
(I-J) 
Std. Error Sig. 99% Confidence 
Interval 
Upper Bound 
40 0 -7,7500
*
 2,43450 ,002 -1,1503 
80 0 -14,9831
*
 2,43450 ,000 -8,3834 
160 0 -57,2715
*
 2,43450 ,000 -50,6718 
Based on observed means. 
 The error term is Mean Square(Error) = 160,024. 
*. The mean difference is significant at the ,01 level. 
a. Dunnett t-tests treat one group as a control, and compare all other groups against it. 
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Homogeneous Subsets 
 
Cell type 
Multiple Comparisons 
Dependent Variable: Cell viability (%)  
 Dunnett t (<control) 
(I) Cell type (J) Cell type Mean Difference 
(I-J) 
Std. Error Sig. 99% Confidence 
Interval 
Upper Bound 
HGF V-79 -2,1470 2,10834 ,249 3,2946 
Wi-38 V-79 ,6564 2,10834 ,780 6,0980 
Based on observed means. 
 The error term is Mean Square(Error) = 160,024. 
a. Dunnett t-tests treat one group as a control, and compare all other groups against it. 
 
Profile Plots 
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Univariate Analysis of Variance Form 
 
Tests of Between-Subjects Effects 
Dependent Variable: Cell viability (%) 
Source Type III Sum 
of Squares 
df Mean 
Square 
F Sig. Noncent. 
Parameter 
Observed 
Power
b
 
Corrected Model 137201,554
a
 11 12472,869 110,647 ,000 1217,118 1,000 
Intercept 811302,491 1 811302,491 
7197,08
3 
,000 7197,083 1,000 
Concentration 117295,729 3 39098,576 346,844 ,000 1040,533 1,000 
Celltype 14997,079 2 7498,539 66,520 ,000 133,039 1,000 
Concentration * 
Celltype 
4908,746 6 818,124 7,258 ,000 43,546 ,998 
Error 22996,221 204 112,727     
Total 971500,266 216      
Corrected Total 160197,775 215      
a. R Squared = ,856 (Adjusted R Squared = ,849) 
b. Computed using alpha = ,01 
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Post Hoc Tests 
 
Concentration 
 
Multiple Comparisons 
Dependent Variable: Cell viability (%)  
 Dunnett t (<control) 
(I) Concentration (J) Concentration Mean Difference 
(I-J) 
Std. Error Sig. 99% Confidence 
Interval 
Upper Bound 
400 0 -46,0211
*
 2,04330 ,000 -40,4819 
800 0 -50,4621
*
 2,04330 ,000 -44,9229 
1600 0 -60,6983
*
 2,04330 ,000 -55,1592 
Based on observed means. 
 The error term is Mean Square(Error) = 112,727. 
*. The mean difference is significant at the ,01 level. 
a. Dunnett t-tests treat one group as a control, and compare all other groups against it. 
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Homogeneous Subsets 
 
Cell type 
Multiple Comparisons 
Dependent Variable: Cell viability (%)  
 Dunnett t (<control) 
(I) Cell type (J) Cell type Mean Difference 
(I-J) 
Std. Error Sig. 99% Confidence 
Interval 
Upper Bound 
HGF V-79 12,8409 1,76955 1,000 17,4081 
Wi-38 V-79 20,1599 1,76955 1,000 24,7271 
Based on observed means. 
 The error term is Mean Square(Error) = 112,727. 
a. Dunnett t-tests treat one group as a control, and compare all other groups against it. 
 
Profile Plots 
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H.2. Genotoxicity Test Statistical Analysis Output 
 
 For further details on the statistical analysis, please consult the respective file 
on the annexed CD. 
 
T-Test 
 
Independent Samples Test 
 
Levene's Test 
for Equality of 
Variances t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
%cells 
- MN 
(2000) 
Equal 
variances 
assumed 
19,306 ,000 323,336 39998 ,000 5,4478118 ,0168488 5,4147878 5,4808357 
Equal 
variances 
not 
assumed 
  
323,336 38623,580 ,000 5,4478118 ,0168488 5,4147878 5,4808357 
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ANOVA 
%cells MN/2000 cells 
 Sum of Squares df Mean Square F Sig. 
Between Groups 83613,345 4 20903,336 2558,857 ,000 
Within Groups 326719,687 39995 8,169   
Total 410333,031 39999    
 
Robust Tests of Equality of Means 
%cells MN/2000 cells 
 Statistica df1 df2 Sig. 
Welch 2845,078 4 19940,349 ,000 
Brown-Forsythe 2558,857 4 38335,124 ,000 
a. Asymptotically F distributed. 
 
Post Hoc Tests 
 
Multiple Comparisons 
%cells MN/2000 cells 
Dunnett t (>control)
a
 
(I) Toxic Agent (J) Toxic Agent 
Mean 
Difference 
(I-J) Std. Error Sig. 
99% 
Confidence 
Interval 
Lower Bound 
EMS 100 microg/ml 
dimension3 
Control (-) 3,0526508
*
 ,0451913 ,000 2,927394 
MMA 0.0037 mM 
dimension3 
Control (-) -1,0697749 ,0451913 1,000 -1,195032 
MMA 40 mM 
dimension3 
Control (-) -,5079951 ,0451913 1,000 -,633252 
Formaldehyde 100 microM 
dimension3 
Control (-) -,2168691 ,0451913 1,000 -,342126 
a. Dunnett t-tests treat one group as a control, and compare all other groups against it. 
*. The mean difference is significant at the 0.01 level. 
 
Means Plots 
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H.3. Discussion Tables 
 
Table 1. Artificial saliva formulas published in residual monomer leaching studies 
Reference Composition 
Urban VM et al. Dent Mater. 
2009;25(5):662-671. 
Urban VM et al. J Appl Polym Sci. 
2012;123(2):732-739. 
NaCl 
KCl 
CaCl2·2H2O 
NaH2PO4·2H2O 
Na2S·9H2O 
Urea 
0.4 g/L 
0.4 g/L 
0.795 g/L 
0.78 g/L 
0.005 g/L 
1.0 g/L 
Danesh G et al. Exp Toxicol 
Pathol. 2011 Apr 27. 
CaCl2·2H2O 
MgCl2·6H2O 
KH2PO4 
HEPES buffer 
KCl 
0.7 mmol/L 
0.2 mmol/L 
4 mmol/L 
20 mmol/L 
30 mmol/L 
Alawi M et al. Fresenius Environ 
Bull. 2007;16(4):408-414. 
NH4Cl 
MgCl2·6H2O 
KCl 
KSCN 
CaCl2·2H2O 
KH2PO4 
Sodium citrate 
NaHCO3 
Na2HPO4 
233 mg/L 
43 mg/L 
1162 mg/L 
222 mg/L 
210 mg/L 
354 mg/L 
13 mg/L 
535 mg/L 
375 mg/L 
   
  
 
